<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for na_pos 1590890274474 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BENPORATH_SOX2_TARGETS'>BENPORATH_SOX2_TARGETS</a></td><td><a href='BENPORATH_SOX2_TARGETS.html'>Details ...</a></td><td>26</td><td>0.57</td><td>1.75</td><td>0.000</td><td>0.321</td><td>0.278</td><td>377</td><td>tags=69%, list=33%, signal=101%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BERENJENO_TRANSFORMED_BY_RHOA_UP'>BERENJENO_TRANSFORMED_BY_RHOA_UP</a></td><td><a href='BERENJENO_TRANSFORMED_BY_RHOA_UP.html'>Details ...</a></td><td>24</td><td>0.55</td><td>1.66</td><td>0.002</td><td>0.542</td><td>0.673</td><td>210</td><td>tags=50%, list=18%, signal=60%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6'>SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6</a></td><td><a href='SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6.html'>Details ...</a></td><td>25</td><td>0.53</td><td>1.63</td><td>0.001</td><td>0.510</td><td>0.803</td><td>423</td><td>tags=76%, list=37%, signal=118%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WANG_SMARCE1_TARGETS_DN'>WANG_SMARCE1_TARGETS_DN</a></td><td><a href='WANG_SMARCE1_TARGETS_DN.html'>Details ...</a></td><td>19</td><td>0.55</td><td>1.62</td><td>0.005</td><td>0.479</td><td>0.863</td><td>237</td><td>tags=47%, list=21%, signal=59%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MIKKELSEN_NPC_HCP_WITH_H3K27ME3'>MIKKELSEN_NPC_HCP_WITH_H3K27ME3</a></td><td><a href='MIKKELSEN_NPC_HCP_WITH_H3K27ME3.html'>Details ...</a></td><td>15</td><td>0.57</td><td>1.58</td><td>0.013</td><td>0.607</td><td>0.950</td><td>245</td><td>tags=53%, list=21%, signal=67%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KAYO_AGING_MUSCLE_UP'>KAYO_AGING_MUSCLE_UP</a></td><td><a href='KAYO_AGING_MUSCLE_UP.html'>Details ...</a></td><td>17</td><td>0.54</td><td>1.55</td><td>0.010</td><td>0.643</td><td>0.978</td><td>292</td><td>tags=59%, list=26%, signal=78%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BENPORATH_NANOG_TARGETS'>BENPORATH_NANOG_TARGETS</a></td><td><a href='BENPORATH_NANOG_TARGETS.html'>Details ...</a></td><td>41</td><td>0.48</td><td>1.55</td><td>0.003</td><td>0.557</td><td>0.980</td><td>395</td><td>tags=59%, list=34%, signal=86%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/TIEN_INTESTINE_PROBIOTICS_24HR_UP'>TIEN_INTESTINE_PROBIOTICS_24HR_UP</a></td><td><a href='TIEN_INTESTINE_PROBIOTICS_24HR_UP.html'>Details ...</a></td><td>28</td><td>0.50</td><td>1.54</td><td>0.003</td><td>0.553</td><td>0.986</td><td>406</td><td>tags=64%, list=35%, signal=97%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP'>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP</a></td><td><a href='TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP.html'>Details ...</a></td><td>16</td><td>0.53</td><td>1.52</td><td>0.012</td><td>0.621</td><td>0.996</td><td>480</td><td>tags=75%, list=42%, signal=127%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BENPORATH_ES_1'>BENPORATH_ES_1</a></td><td><a href='BENPORATH_ES_1.html'>Details ...</a></td><td>17</td><td>0.52</td><td>1.52</td><td>0.022</td><td>0.565</td><td>0.996</td><td>396</td><td>tags=71%, list=35%, signal=106%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_UP'>DACOSTA_UV_RESPONSE_VIA_ERCC3_UP</a></td><td><a href='DACOSTA_UV_RESPONSE_VIA_ERCC3_UP.html'>Details ...</a></td><td>16</td><td>0.53</td><td>1.51</td><td>0.022</td><td>0.547</td><td>0.997</td><td>295</td><td>tags=56%, list=26%, signal=75%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ONKEN_UVEAL_MELANOMA_DN'>ONKEN_UVEAL_MELANOMA_DN</a></td><td><a href='ONKEN_UVEAL_MELANOMA_DN.html'>Details ...</a></td><td>24</td><td>0.50</td><td>1.51</td><td>0.012</td><td>0.516</td><td>0.997</td><td>352</td><td>tags=63%, list=31%, signal=88%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CAIRO_HEPATOBLASTOMA_CLASSES_UP'>CAIRO_HEPATOBLASTOMA_CLASSES_UP</a></td><td><a href='CAIRO_HEPATOBLASTOMA_CLASSES_UP.html'>Details ...</a></td><td>33</td><td>0.47</td><td>1.51</td><td>0.011</td><td>0.478</td><td>0.997</td><td>342</td><td>tags=55%, list=30%, signal=76%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE'>REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE</a></td><td><a href='REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE.html'>Details ...</a></td><td>16</td><td>0.53</td><td>1.51</td><td>0.017</td><td>0.455</td><td>0.997</td><td>352</td><td>tags=56%, list=31%, signal=80%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_2_UP'>ONDER_CDH1_TARGETS_2_UP</a></td><td><a href='ONDER_CDH1_TARGETS_2_UP.html'>Details ...</a></td><td>17</td><td>0.52</td><td>1.50</td><td>0.020</td><td>0.450</td><td>0.997</td><td>475</td><td>tags=76%, list=41%, signal=129%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN'>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN</a></td><td><a href='CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN.html'>Details ...</a></td><td>32</td><td>0.47</td><td>1.49</td><td>0.015</td><td>0.483</td><td>0.998</td><td>326</td><td>tags=50%, list=28%, signal=68%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3K27ME3'>MEISSNER_BRAIN_HCP_WITH_H3K27ME3</a></td><td><a href='MEISSNER_BRAIN_HCP_WITH_H3K27ME3.html'>Details ...</a></td><td>19</td><td>0.50</td><td>1.47</td><td>0.018</td><td>0.545</td><td>1.000</td><td>245</td><td>tags=53%, list=21%, signal=66%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WONG_EMBRYONIC_STEM_CELL_CORE'>WONG_EMBRYONIC_STEM_CELL_CORE</a></td><td><a href='WONG_EMBRYONIC_STEM_CELL_CORE.html'>Details ...</a></td><td>19</td><td>0.50</td><td>1.46</td><td>0.032</td><td>0.561</td><td>1.000</td><td>316</td><td>tags=53%, list=28%, signal=71%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PUJANA_CHEK2_PCC_NETWORK'>PUJANA_CHEK2_PCC_NETWORK</a></td><td><a href='PUJANA_CHEK2_PCC_NETWORK.html'>Details ...</a></td><td>21</td><td>0.49</td><td>1.46</td><td>0.019</td><td>0.538</td><td>1.000</td><td>262</td><td>tags=48%, list=23%, signal=61%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN'>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN</a></td><td><a href='RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN.html'>Details ...</a></td><td>26</td><td>0.47</td><td>1.46</td><td>0.030</td><td>0.515</td><td>1.000</td><td>292</td><td>tags=46%, list=26%, signal=61%</td></tr><tr><td class='lessen'>21</td><td>ACEVEDO_LIVER_CANCER_UP</td><td></td><td>37</td><td>0.45</td><td>1.46</td><td>0.014</td><td>0.499</td><td>1.000</td><td>386</td><td>tags=59%, list=34%, signal=87%</td></tr><tr><td class='lessen'>22</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D</td><td></td><td>28</td><td>0.47</td><td>1.45</td><td>0.019</td><td>0.505</td><td>1.000</td><td>386</td><td>tags=54%, list=34%, signal=79%</td></tr><tr><td class='lessen'>23</td><td>WIERENGA_STAT5A_TARGETS_DN</td><td></td><td>18</td><td>0.50</td><td>1.45</td><td>0.041</td><td>0.497</td><td>1.000</td><td>454</td><td>tags=67%, list=40%, signal=109%</td></tr><tr><td class='lessen'>24</td><td>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP</td><td></td><td>16</td><td>0.51</td><td>1.45</td><td>0.031</td><td>0.485</td><td>1.000</td><td>352</td><td>tags=63%, list=31%, signal=89%</td></tr><tr><td class='lessen'>25</td><td>VERHAAK_AML_WITH_NPM1_MUTATED_UP</td><td></td><td>15</td><td>0.51</td><td>1.44</td><td>0.037</td><td>0.472</td><td>1.000</td><td>186</td><td>tags=47%, list=16%, signal=55%</td></tr><tr><td class='lessen'>26</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>16</td><td>0.51</td><td>1.44</td><td>0.038</td><td>0.457</td><td>1.000</td><td>227</td><td>tags=44%, list=20%, signal=54%</td></tr><tr><td class='lessen'>27</td><td>MARSON_BOUND_BY_FOXP3_STIMULATED</td><td></td><td>51</td><td>0.43</td><td>1.44</td><td>0.013</td><td>0.455</td><td>1.000</td><td>415</td><td>tags=55%, list=36%, signal=82%</td></tr><tr><td class='lessen'>28</td><td>KOYAMA_SEMA3B_TARGETS_DN</td><td></td><td>17</td><td>0.50</td><td>1.44</td><td>0.039</td><td>0.441</td><td>1.000</td><td>348</td><td>tags=53%, list=30%, signal=75%</td></tr><tr><td class='lessen'>29</td><td>MIKKELSEN_MEF_HCP_WITH_H3K27ME3</td><td></td><td>33</td><td>0.45</td><td>1.44</td><td>0.021</td><td>0.426</td><td>1.000</td><td>371</td><td>tags=55%, list=32%, signal=78%</td></tr><tr><td class='lessen'>30</td><td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP</td><td></td><td>19</td><td>0.49</td><td>1.42</td><td>0.041</td><td>0.470</td><td>1.000</td><td>331</td><td>tags=63%, list=29%, signal=87%</td></tr><tr><td class='lessen'>31</td><td>MIKKELSEN_MEF_ICP_WITH_H3K27ME3</td><td></td><td>21</td><td>0.48</td><td>1.42</td><td>0.031</td><td>0.479</td><td>1.000</td><td>307</td><td>tags=52%, list=27%, signal=70%</td></tr><tr><td class='lessen'>32</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D</td><td></td><td>33</td><td>0.44</td><td>1.42</td><td>0.016</td><td>0.468</td><td>1.000</td><td>525</td><td>tags=73%, list=46%, signal=130%</td></tr><tr><td class='lessen'>33</td><td>JOHNSTONE_PARVB_TARGETS_3_DN</td><td></td><td>25</td><td>0.45</td><td>1.40</td><td>0.041</td><td>0.518</td><td>1.000</td><td>520</td><td>tags=76%, list=45%, signal=136%</td></tr><tr><td class='lessen'>34</td><td>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP</td><td></td><td>15</td><td>0.50</td><td>1.40</td><td>0.057</td><td>0.518</td><td>1.000</td><td>250</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>35</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN</td><td></td><td>29</td><td>0.44</td><td>1.39</td><td>0.041</td><td>0.540</td><td>1.000</td><td>372</td><td>tags=55%, list=32%, signal=80%</td></tr><tr><td class='lessen'>36</td><td>GEORGES_TARGETS_OF_MIR192_AND_MIR215</td><td></td><td>44</td><td>0.42</td><td>1.39</td><td>0.024</td><td>0.531</td><td>1.000</td><td>411</td><td>tags=57%, list=36%, signal=85%</td></tr><tr><td class='lessen'>37</td><td>VECCHI_GASTRIC_CANCER_EARLY_UP</td><td></td><td>27</td><td>0.45</td><td>1.39</td><td>0.039</td><td>0.524</td><td>1.000</td><td>233</td><td>tags=44%, list=20%, signal=54%</td></tr><tr><td class='lessen'>38</td><td>PUJANA_BRCA1_PCC_NETWORK</td><td></td><td>62</td><td>0.41</td><td>1.39</td><td>0.010</td><td>0.518</td><td>1.000</td><td>329</td><td>tags=45%, list=29%, signal=60%</td></tr><tr><td class='lessen'>39</td><td>ENK_UV_RESPONSE_KERATINOCYTE_DN</td><td></td><td>20</td><td>0.47</td><td>1.39</td><td>0.054</td><td>0.506</td><td>1.000</td><td>316</td><td>tags=55%, list=28%, signal=75%</td></tr><tr><td class='lessen'>40</td><td>REACTOME_G_ALPHA_S_SIGNALLING_EVENTS</td><td></td><td>20</td><td>0.47</td><td>1.38</td><td>0.054</td><td>0.504</td><td>1.000</td><td>435</td><td>tags=65%, list=38%, signal=103%</td></tr><tr><td class='lessen'>41</td><td>ENK_UV_RESPONSE_EPIDERMIS_UP</td><td></td><td>17</td><td>0.47</td><td>1.38</td><td>0.067</td><td>0.512</td><td>1.000</td><td>199</td><td>tags=41%, list=17%, signal=49%</td></tr><tr><td class='lessen'>42</td><td>HAN_SATB1_TARGETS_UP</td><td></td><td>18</td><td>0.47</td><td>1.38</td><td>0.066</td><td>0.512</td><td>1.000</td><td>356</td><td>tags=50%, list=31%, signal=71%</td></tr><tr><td class='lessen'>43</td><td>GARY_CD5_TARGETS_DN</td><td></td><td>16</td><td>0.49</td><td>1.38</td><td>0.074</td><td>0.503</td><td>1.000</td><td>538</td><td>tags=81%, list=47%, signal=151%</td></tr><tr><td class='lessen'>44</td><td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP</td><td></td><td>51</td><td>0.41</td><td>1.37</td><td>0.019</td><td>0.501</td><td>1.000</td><td>553</td><td>tags=71%, list=48%, signal=130%</td></tr><tr><td class='lessen'>45</td><td>MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>38</td><td>0.43</td><td>1.37</td><td>0.037</td><td>0.491</td><td>1.000</td><td>604</td><td>tags=79%, list=53%, signal=162%</td></tr><tr><td class='lessen'>46</td><td>ZHOU_INFLAMMATORY_RESPONSE_LPS_UP</td><td></td><td>18</td><td>0.47</td><td>1.37</td><td>0.070</td><td>0.506</td><td>1.000</td><td>462</td><td>tags=72%, list=40%, signal=119%</td></tr><tr><td class='lessen'>47</td><td>REACTOME_METABOLISM_OF_LIPIDS</td><td></td><td>47</td><td>0.41</td><td>1.37</td><td>0.027</td><td>0.496</td><td>1.000</td><td>504</td><td>tags=60%, list=44%, signal=102%</td></tr><tr><td class='lessen'>48</td><td>WEST_ADRENOCORTICAL_TUMOR_UP</td><td></td><td>15</td><td>0.49</td><td>1.36</td><td>0.079</td><td>0.499</td><td>1.000</td><td>480</td><td>tags=73%, list=42%, signal=125%</td></tr><tr><td class='lessen'>49</td><td>FOSTER_TOLERANT_MACROPHAGE_DN</td><td></td><td>22</td><td>0.45</td><td>1.36</td><td>0.055</td><td>0.489</td><td>1.000</td><td>98</td><td>tags=32%, list=9%, signal=34%</td></tr><tr><td class='lessen'>50</td><td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN</td><td></td><td>24</td><td>0.45</td><td>1.36</td><td>0.052</td><td>0.480</td><td>1.000</td><td>401</td><td>tags=50%, list=35%, signal=75%</td></tr><tr><td class='lessen'>51</td><td>FEVR_CTNNB1_TARGETS_DN</td><td></td><td>21</td><td>0.46</td><td>1.36</td><td>0.057</td><td>0.482</td><td>1.000</td><td>343</td><td>tags=48%, list=30%, signal=67%</td></tr><tr><td class='lessen'>52</td><td>REACTOME_INFECTIOUS_DISEASE</td><td></td><td>34</td><td>0.42</td><td>1.36</td><td>0.052</td><td>0.481</td><td>1.000</td><td>359</td><td>tags=50%, list=31%, signal=71%</td></tr><tr><td class='lessen'>53</td><td>RIGGI_EWING_SARCOMA_PROGENITOR_UP</td><td></td><td>26</td><td>0.44</td><td>1.36</td><td>0.054</td><td>0.487</td><td>1.000</td><td>349</td><td>tags=46%, list=30%, signal=65%</td></tr><tr><td class='lessen'>54</td><td>REACTOME_HEMOSTASIS</td><td></td><td>30</td><td>0.43</td><td>1.35</td><td>0.046</td><td>0.482</td><td>1.000</td><td>238</td><td>tags=40%, list=21%, signal=49%</td></tr><tr><td class='lessen'>55</td><td>NUYTTEN_NIPP1_TARGETS_UP</td><td></td><td>32</td><td>0.43</td><td>1.35</td><td>0.047</td><td>0.482</td><td>1.000</td><td>475</td><td>tags=66%, list=41%, signal=109%</td></tr><tr><td class='lessen'>56</td><td>REACTOME_CELL_CYCLE</td><td></td><td>32</td><td>0.43</td><td>1.35</td><td>0.037</td><td>0.483</td><td>1.000</td><td>504</td><td>tags=66%, list=44%, signal=114%</td></tr><tr><td class='lessen'>57</td><td>GRYDER_PAX3FOXO1_TOP_ENHANCERS</td><td></td><td>28</td><td>0.43</td><td>1.35</td><td>0.055</td><td>0.476</td><td>1.000</td><td>544</td><td>tags=75%, list=48%, signal=139%</td></tr><tr><td class='lessen'>58</td><td>BHAT_ESR1_TARGETS_VIA_AKT1_UP</td><td></td><td>18</td><td>0.47</td><td>1.35</td><td>0.074</td><td>0.471</td><td>1.000</td><td>517</td><td>tags=78%, list=45%, signal=140%</td></tr><tr><td class='lessen'>59</td><td>RAO_BOUND_BY_SALL4_ISOFORM_B</td><td></td><td>35</td><td>0.42</td><td>1.35</td><td>0.042</td><td>0.466</td><td>1.000</td><td>352</td><td>tags=51%, list=31%, signal=72%</td></tr><tr><td class='lessen'>60</td><td>BRUINS_UVC_RESPONSE_LATE</td><td></td><td>52</td><td>0.40</td><td>1.35</td><td>0.022</td><td>0.462</td><td>1.000</td><td>345</td><td>tags=46%, list=30%, signal=63%</td></tr><tr><td class='lessen'>61</td><td>JAATINEN_HEMATOPOIETIC_STEM_CELL_UP</td><td></td><td>17</td><td>0.47</td><td>1.34</td><td>0.078</td><td>0.461</td><td>1.000</td><td>232</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>62</td><td>ZHENG_BOUND_BY_FOXP3</td><td></td><td>22</td><td>0.45</td><td>1.34</td><td>0.073</td><td>0.466</td><td>1.000</td><td>485</td><td>tags=64%, list=42%, signal=108%</td></tr><tr><td class='lessen'>63</td><td>GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN</td><td></td><td>35</td><td>0.42</td><td>1.34</td><td>0.052</td><td>0.467</td><td>1.000</td><td>334</td><td>tags=49%, list=29%, signal=66%</td></tr><tr><td class='lessen'>64</td><td>ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>28</td><td>0.43</td><td>1.34</td><td>0.068</td><td>0.461</td><td>1.000</td><td>224</td><td>tags=39%, list=20%, signal=48%</td></tr><tr><td class='lessen'>65</td><td>PILON_KLF1_TARGETS_UP</td><td></td><td>24</td><td>0.44</td><td>1.34</td><td>0.073</td><td>0.454</td><td>1.000</td><td>271</td><td>tags=42%, list=24%, signal=53%</td></tr><tr><td class='lessen'>66</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1</td><td></td><td>17</td><td>0.47</td><td>1.34</td><td>0.095</td><td>0.452</td><td>1.000</td><td>235</td><td>tags=47%, list=21%, signal=58%</td></tr><tr><td class='lessen'>67</td><td>MIKKELSEN_MCV6_HCP_WITH_H3K27ME3</td><td></td><td>29</td><td>0.43</td><td>1.34</td><td>0.053</td><td>0.453</td><td>1.000</td><td>403</td><td>tags=55%, list=35%, signal=83%</td></tr><tr><td class='lessen'>68</td><td>REACTOME_CELL_CYCLE_MITOTIC</td><td></td><td>26</td><td>0.43</td><td>1.33</td><td>0.072</td><td>0.459</td><td>1.000</td><td>504</td><td>tags=65%, list=44%, signal=114%</td></tr><tr><td class='lessen'>69</td><td>HSIAO_HOUSEKEEPING_GENES</td><td></td><td>22</td><td>0.44</td><td>1.33</td><td>0.081</td><td>0.468</td><td>1.000</td><td>249</td><td>tags=45%, list=22%, signal=57%</td></tr><tr><td class='lessen'>70</td><td>WALLACE_PROSTATE_CANCER_RACE_UP</td><td></td><td>15</td><td>0.47</td><td>1.32</td><td>0.104</td><td>0.474</td><td>1.000</td><td>481</td><td>tags=67%, list=42%, signal=113%</td></tr><tr><td class='lessen'>71</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP</td><td></td><td>27</td><td>0.43</td><td>1.32</td><td>0.071</td><td>0.468</td><td>1.000</td><td>168</td><td>tags=37%, list=15%, signal=42%</td></tr><tr><td class='lessen'>72</td><td>YOSHIMURA_MAPK8_TARGETS_DN</td><td></td><td>16</td><td>0.47</td><td>1.32</td><td>0.098</td><td>0.463</td><td>1.000</td><td>460</td><td>tags=63%, list=40%, signal=103%</td></tr><tr><td class='lessen'>73</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN</td><td></td><td>24</td><td>0.44</td><td>1.32</td><td>0.078</td><td>0.464</td><td>1.000</td><td>386</td><td>tags=54%, list=34%, signal=80%</td></tr><tr><td class='lessen'>74</td><td>SENESE_HDAC3_TARGETS_DN</td><td></td><td>25</td><td>0.43</td><td>1.32</td><td>0.073</td><td>0.467</td><td>1.000</td><td>468</td><td>tags=68%, list=41%, signal=112%</td></tr><tr><td class='lessen'>75</td><td>WANG_MLL_TARGETS</td><td></td><td>16</td><td>0.46</td><td>1.32</td><td>0.104</td><td>0.463</td><td>1.000</td><td>172</td><td>tags=38%, list=15%, signal=44%</td></tr><tr><td class='lessen'>76</td><td>COLDREN_GEFITINIB_RESISTANCE_DN</td><td></td><td>17</td><td>0.46</td><td>1.31</td><td>0.098</td><td>0.474</td><td>1.000</td><td>398</td><td>tags=65%, list=35%, signal=98%</td></tr><tr><td class='lessen'>77</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7</td><td></td><td>26</td><td>0.43</td><td>1.31</td><td>0.080</td><td>0.481</td><td>1.000</td><td>406</td><td>tags=62%, list=35%, signal=93%</td></tr><tr><td class='lessen'>78</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP</td><td></td><td>20</td><td>0.44</td><td>1.31</td><td>0.099</td><td>0.475</td><td>1.000</td><td>323</td><td>tags=50%, list=28%, signal=68%</td></tr><tr><td class='lessen'>79</td><td>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP</td><td></td><td>15</td><td>0.47</td><td>1.31</td><td>0.119</td><td>0.469</td><td>1.000</td><td>270</td><td>tags=47%, list=24%, signal=60%</td></tr><tr><td class='lessen'>80</td><td>KEGG_PURINE_METABOLISM</td><td></td><td>15</td><td>0.46</td><td>1.31</td><td>0.122</td><td>0.473</td><td>1.000</td><td>428</td><td>tags=67%, list=37%, signal=105%</td></tr><tr><td class='lessen'>81</td><td>DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN</td><td></td><td>31</td><td>0.42</td><td>1.31</td><td>0.079</td><td>0.469</td><td>1.000</td><td>526</td><td>tags=71%, list=46%, signal=128%</td></tr><tr><td class='lessen'>82</td><td>BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING</td><td></td><td>34</td><td>0.41</td><td>1.30</td><td>0.066</td><td>0.475</td><td>1.000</td><td>576</td><td>tags=74%, list=50%, signal=144%</td></tr><tr><td class='lessen'>83</td><td>BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP</td><td></td><td>15</td><td>0.47</td><td>1.30</td><td>0.109</td><td>0.478</td><td>1.000</td><td>358</td><td>tags=60%, list=31%, signal=86%</td></tr><tr><td class='lessen'>84</td><td>GOLDRATH_ANTIGEN_RESPONSE</td><td></td><td>22</td><td>0.43</td><td>1.30</td><td>0.091</td><td>0.484</td><td>1.000</td><td>311</td><td>tags=45%, list=27%, signal=61%</td></tr><tr><td class='lessen'>85</td><td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN</td><td></td><td>21</td><td>0.44</td><td>1.30</td><td>0.093</td><td>0.482</td><td>1.000</td><td>400</td><td>tags=52%, list=35%, signal=79%</td></tr><tr><td class='lessen'>86</td><td>REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES</td><td></td><td>23</td><td>0.43</td><td>1.29</td><td>0.111</td><td>0.487</td><td>1.000</td><td>95</td><td>tags=30%, list=8%, signal=33%</td></tr><tr><td class='lessen'>87</td><td>KEGG_PATHWAYS_IN_CANCER</td><td></td><td>20</td><td>0.43</td><td>1.29</td><td>0.108</td><td>0.488</td><td>1.000</td><td>531</td><td>tags=75%, list=46%, signal=137%</td></tr><tr><td class='lessen'>88</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_DN</td><td></td><td>17</td><td>0.45</td><td>1.29</td><td>0.115</td><td>0.494</td><td>1.000</td><td>210</td><td>tags=41%, list=18%, signal=50%</td></tr><tr><td class='lessen'>89</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_UP</td><td></td><td>47</td><td>0.38</td><td>1.28</td><td>0.070</td><td>0.504</td><td>1.000</td><td>540</td><td>tags=66%, list=47%, signal=120%</td></tr><tr><td class='lessen'>90</td><td>GRUETZMANN_PANCREATIC_CANCER_UP</td><td></td><td>23</td><td>0.42</td><td>1.28</td><td>0.113</td><td>0.505</td><td>1.000</td><td>600</td><td>tags=87%, list=52%, signal=179%</td></tr><tr><td class='lessen'>91</td><td>REN_ALVEOLAR_RHABDOMYOSARCOMA_DN</td><td></td><td>24</td><td>0.42</td><td>1.28</td><td>0.120</td><td>0.518</td><td>1.000</td><td>455</td><td>tags=67%, list=40%, signal=108%</td></tr><tr><td class='lessen'>92</td><td>FISCHER_DREAM_TARGETS</td><td></td><td>38</td><td>0.39</td><td>1.27</td><td>0.080</td><td>0.528</td><td>1.000</td><td>406</td><td>tags=55%, list=35%, signal=83%</td></tr><tr><td class='lessen'>93</td><td>REACTOME_GPCR_LIGAND_BINDING</td><td></td><td>41</td><td>0.39</td><td>1.27</td><td>0.082</td><td>0.539</td><td>1.000</td><td>294</td><td>tags=41%, list=26%, signal=54%</td></tr><tr><td class='lessen'>94</td><td>REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION</td><td></td><td>56</td><td>0.38</td><td>1.27</td><td>0.079</td><td>0.538</td><td>1.000</td><td>567</td><td>tags=66%, list=50%, signal=124%</td></tr><tr><td class='lessen'>95</td><td>ROZANOV_MMP14_TARGETS_UP</td><td></td><td>15</td><td>0.45</td><td>1.27</td><td>0.134</td><td>0.535</td><td>1.000</td><td>444</td><td>tags=53%, list=39%, signal=86%</td></tr><tr><td class='lessen'>96</td><td>REACTOME_M_PHASE</td><td></td><td>20</td><td>0.42</td><td>1.27</td><td>0.135</td><td>0.530</td><td>1.000</td><td>504</td><td>tags=65%, list=44%, signal=114%</td></tr><tr><td class='lessen'>97</td><td>HAMAI_APOPTOSIS_VIA_TRAIL_UP</td><td></td><td>27</td><td>0.41</td><td>1.26</td><td>0.110</td><td>0.531</td><td>1.000</td><td>358</td><td>tags=52%, list=31%, signal=74%</td></tr><tr><td class='lessen'>98</td><td>ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP</td><td></td><td>28</td><td>0.40</td><td>1.26</td><td>0.105</td><td>0.527</td><td>1.000</td><td>346</td><td>tags=50%, list=30%, signal=70%</td></tr><tr><td class='lessen'>99</td><td>BENPORATH_SUZ12_TARGETS</td><td></td><td>39</td><td>0.39</td><td>1.26</td><td>0.081</td><td>0.532</td><td>1.000</td><td>292</td><td>tags=41%, list=26%, signal=53%</td></tr><tr><td class='lessen'>100</td><td>DOUGLAS_BMI1_TARGETS_UP</td><td></td><td>31</td><td>0.40</td><td>1.25</td><td>0.105</td><td>0.550</td><td>1.000</td><td>417</td><td>tags=55%, list=36%, signal=84%</td></tr><tr><td class='lessen'>101</td><td>PATIL_LIVER_CANCER</td><td></td><td>27</td><td>0.41</td><td>1.25</td><td>0.133</td><td>0.552</td><td>1.000</td><td>423</td><td>tags=63%, list=37%, signal=97%</td></tr><tr><td class='lessen'>102</td><td>MOHANKUMAR_HOXA1_TARGETS_UP</td><td></td><td>18</td><td>0.43</td><td>1.25</td><td>0.145</td><td>0.550</td><td>1.000</td><td>495</td><td>tags=67%, list=43%, signal=116%</td></tr><tr><td class='lessen'>103</td><td>VECCHI_GASTRIC_CANCER_EARLY_DN</td><td></td><td>21</td><td>0.42</td><td>1.25</td><td>0.153</td><td>0.545</td><td>1.000</td><td>445</td><td>tags=52%, list=39%, signal=84%</td></tr><tr><td class='lessen'>104</td><td>KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP</td><td></td><td>36</td><td>0.39</td><td>1.25</td><td>0.100</td><td>0.540</td><td>1.000</td><td>395</td><td>tags=50%, list=34%, signal=74%</td></tr><tr><td class='lessen'>105</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP</td><td></td><td>16</td><td>0.44</td><td>1.25</td><td>0.154</td><td>0.535</td><td>1.000</td><td>365</td><td>tags=50%, list=32%, signal=72%</td></tr><tr><td class='lessen'>106</td><td>YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN</td><td></td><td>19</td><td>0.43</td><td>1.25</td><td>0.160</td><td>0.530</td><td>1.000</td><td>440</td><td>tags=53%, list=38%, signal=84%</td></tr><tr><td class='lessen'>107</td><td>YANG_BCL3_TARGETS_UP</td><td></td><td>24</td><td>0.41</td><td>1.25</td><td>0.131</td><td>0.533</td><td>1.000</td><td>520</td><td>tags=67%, list=45%, signal=120%</td></tr><tr><td class='lessen'>108</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP</td><td></td><td>21</td><td>0.42</td><td>1.25</td><td>0.134</td><td>0.534</td><td>1.000</td><td>445</td><td>tags=62%, list=39%, signal=99%</td></tr><tr><td class='lessen'>109</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN</td><td></td><td>15</td><td>0.45</td><td>1.25</td><td>0.171</td><td>0.534</td><td>1.000</td><td>408</td><td>tags=47%, list=36%, signal=72%</td></tr><tr><td class='lessen'>110</td><td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN</td><td></td><td>25</td><td>0.40</td><td>1.24</td><td>0.148</td><td>0.537</td><td>1.000</td><td>423</td><td>tags=52%, list=37%, signal=81%</td></tr><tr><td class='lessen'>111</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN</td><td></td><td>16</td><td>0.44</td><td>1.24</td><td>0.157</td><td>0.533</td><td>1.000</td><td>270</td><td>tags=44%, list=24%, signal=56%</td></tr><tr><td class='lessen'>112</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3</td><td></td><td>15</td><td>0.44</td><td>1.24</td><td>0.168</td><td>0.530</td><td>1.000</td><td>371</td><td>tags=53%, list=32%, signal=78%</td></tr><tr><td class='lessen'>113</td><td>VANTVEER_BREAST_CANCER_ESR1_DN</td><td></td><td>17</td><td>0.43</td><td>1.24</td><td>0.151</td><td>0.527</td><td>1.000</td><td>517</td><td>tags=65%, list=45%, signal=116%</td></tr><tr><td class='lessen'>114</td><td>SENESE_HDAC1_TARGETS_UP</td><td></td><td>22</td><td>0.41</td><td>1.24</td><td>0.142</td><td>0.534</td><td>1.000</td><td>538</td><td>tags=64%, list=47%, signal=118%</td></tr><tr><td class='lessen'>115</td><td>NUYTTEN_EZH2_TARGETS_DN</td><td></td><td>46</td><td>0.38</td><td>1.24</td><td>0.103</td><td>0.532</td><td>1.000</td><td>466</td><td>tags=57%, list=41%, signal=91%</td></tr><tr><td class='lessen'>116</td><td>FARMER_BREAST_CANCER_APOCRINE_VS_BASAL</td><td></td><td>19</td><td>0.42</td><td>1.24</td><td>0.162</td><td>0.527</td><td>1.000</td><td>590</td><td>tags=68%, list=52%, signal=139%</td></tr><tr><td class='lessen'>117</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP</td><td></td><td>39</td><td>0.38</td><td>1.24</td><td>0.111</td><td>0.530</td><td>1.000</td><td>385</td><td>tags=51%, list=34%, signal=75%</td></tr><tr><td class='lessen'>118</td><td>MARSON_BOUND_BY_E2F4_UNSTIMULATED</td><td></td><td>25</td><td>0.41</td><td>1.24</td><td>0.141</td><td>0.531</td><td>1.000</td><td>163</td><td>tags=36%, list=14%, signal=41%</td></tr><tr><td class='lessen'>119</td><td>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN</td><td></td><td>71</td><td>0.36</td><td>1.23</td><td>0.076</td><td>0.539</td><td>1.000</td><td>569</td><td>tags=65%, list=50%, signal=121%</td></tr><tr><td class='lessen'>120</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP</td><td></td><td>26</td><td>0.40</td><td>1.23</td><td>0.150</td><td>0.545</td><td>1.000</td><td>591</td><td>tags=77%, list=52%, signal=155%</td></tr><tr><td class='lessen'>121</td><td>LANDIS_ERBB2_BREAST_TUMORS_324_DN</td><td></td><td>16</td><td>0.43</td><td>1.23</td><td>0.179</td><td>0.541</td><td>1.000</td><td>453</td><td>tags=56%, list=40%, signal=92%</td></tr><tr><td class='lessen'>122</td><td>REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION</td><td></td><td>24</td><td>0.40</td><td>1.23</td><td>0.147</td><td>0.539</td><td>1.000</td><td>319</td><td>tags=42%, list=28%, signal=57%</td></tr><tr><td class='lessen'>123</td><td>NABA_SECRETED_FACTORS</td><td></td><td>34</td><td>0.38</td><td>1.23</td><td>0.129</td><td>0.536</td><td>1.000</td><td>258</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>124</td><td>CHICAS_RB1_TARGETS_CONFLUENT</td><td></td><td>31</td><td>0.39</td><td>1.22</td><td>0.140</td><td>0.548</td><td>1.000</td><td>454</td><td>tags=52%, list=40%, signal=83%</td></tr><tr><td class='lessen'>125</td><td>DODD_NASOPHARYNGEAL_CARCINOMA_DN</td><td></td><td>65</td><td>0.36</td><td>1.22</td><td>0.106</td><td>0.552</td><td>1.000</td><td>453</td><td>tags=52%, list=40%, signal=82%</td></tr><tr><td class='lessen'>126</td><td>CUI_TCF21_TARGETS_2_UP</td><td></td><td>22</td><td>0.41</td><td>1.22</td><td>0.156</td><td>0.550</td><td>1.000</td><td>520</td><td>tags=55%, list=45%, signal=98%</td></tr><tr><td class='lessen'>127</td><td>MOOTHA_MITOCHONDRIA</td><td></td><td>22</td><td>0.41</td><td>1.22</td><td>0.183</td><td>0.547</td><td>1.000</td><td>209</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>128</td><td>KIM_WT1_TARGETS_DN</td><td></td><td>16</td><td>0.43</td><td>1.22</td><td>0.179</td><td>0.546</td><td>1.000</td><td>620</td><td>tags=94%, list=54%, signal=202%</td></tr><tr><td class='lessen'>129</td><td>MOOTHA_HUMAN_MITODB_6_2002</td><td></td><td>19</td><td>0.42</td><td>1.22</td><td>0.199</td><td>0.542</td><td>1.000</td><td>209</td><td>tags=37%, list=18%, signal=44%</td></tr><tr><td class='lessen'>130</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_DN</td><td></td><td>36</td><td>0.38</td><td>1.22</td><td>0.138</td><td>0.542</td><td>1.000</td><td>576</td><td>tags=72%, list=50%, signal=141%</td></tr><tr><td class='lessen'>131</td><td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN</td><td></td><td>15</td><td>0.43</td><td>1.22</td><td>0.194</td><td>0.545</td><td>1.000</td><td>514</td><td>tags=60%, list=45%, signal=107%</td></tr><tr><td class='lessen'>132</td><td>MARTENS_TRETINOIN_RESPONSE_DN</td><td></td><td>39</td><td>0.37</td><td>1.21</td><td>0.153</td><td>0.557</td><td>1.000</td><td>324</td><td>tags=44%, list=28%, signal=59%</td></tr><tr><td class='lessen'>133</td><td>NUYTTEN_EZH2_TARGETS_UP</td><td></td><td>56</td><td>0.36</td><td>1.21</td><td>0.119</td><td>0.553</td><td>1.000</td><td>421</td><td>tags=52%, list=37%, signal=78%</td></tr><tr><td class='lessen'>134</td><td>DELACROIX_RAR_BOUND_ES</td><td></td><td>25</td><td>0.39</td><td>1.21</td><td>0.173</td><td>0.563</td><td>1.000</td><td>305</td><td>tags=40%, list=27%, signal=53%</td></tr><tr><td class='lessen'>135</td><td>REACTOME_LEISHMANIA_INFECTION</td><td></td><td>18</td><td>0.41</td><td>1.21</td><td>0.188</td><td>0.565</td><td>1.000</td><td>359</td><td>tags=50%, list=31%, signal=72%</td></tr><tr><td class='lessen'>136</td><td>KIM_ALL_DISORDERS_CALB1_CORR_UP</td><td></td><td>26</td><td>0.39</td><td>1.20</td><td>0.179</td><td>0.563</td><td>1.000</td><td>199</td><td>tags=31%, list=17%, signal=36%</td></tr><tr><td class='lessen'>137</td><td>SWEET_LUNG_CANCER_KRAS_UP</td><td></td><td>31</td><td>0.38</td><td>1.20</td><td>0.172</td><td>0.562</td><td>1.000</td><td>568</td><td>tags=68%, list=50%, signal=131%</td></tr><tr><td class='lessen'>138</td><td>TARTE_PLASMA_CELL_VS_PLASMABLAST_UP</td><td></td><td>23</td><td>0.40</td><td>1.20</td><td>0.183</td><td>0.559</td><td>1.000</td><td>562</td><td>tags=65%, list=49%, signal=126%</td></tr><tr><td class='lessen'>139</td><td>MARSON_BOUND_BY_FOXP3_UNSTIMULATED</td><td></td><td>50</td><td>0.36</td><td>1.20</td><td>0.136</td><td>0.562</td><td>1.000</td><td>405</td><td>tags=48%, list=35%, signal=71%</td></tr><tr><td class='lessen'>140</td><td>ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN</td><td></td><td>21</td><td>0.40</td><td>1.20</td><td>0.193</td><td>0.560</td><td>1.000</td><td>327</td><td>tags=38%, list=29%, signal=52%</td></tr><tr><td class='lessen'>141</td><td>MARTINEZ_RB1_TARGETS_UP</td><td></td><td>48</td><td>0.36</td><td>1.20</td><td>0.129</td><td>0.558</td><td>1.000</td><td>544</td><td>tags=65%, list=48%, signal=118%</td></tr><tr><td class='lessen'>142</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN</td><td></td><td>20</td><td>0.41</td><td>1.20</td><td>0.182</td><td>0.560</td><td>1.000</td><td>358</td><td>tags=50%, list=31%, signal=71%</td></tr><tr><td class='lessen'>143</td><td>REACTOME_G_ALPHA_I_SIGNALLING_EVENTS</td><td></td><td>29</td><td>0.39</td><td>1.19</td><td>0.188</td><td>0.570</td><td>1.000</td><td>504</td><td>tags=59%, list=44%, signal=102%</td></tr><tr><td class='lessen'>144</td><td>DURAND_STROMA_NS_UP</td><td></td><td>15</td><td>0.42</td><td>1.19</td><td>0.214</td><td>0.567</td><td>1.000</td><td>431</td><td>tags=67%, list=38%, signal=106%</td></tr><tr><td class='lessen'>145</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP</td><td></td><td>28</td><td>0.39</td><td>1.19</td><td>0.186</td><td>0.570</td><td>1.000</td><td>60</td><td>tags=25%, list=5%, signal=26%</td></tr><tr><td class='lessen'>146</td><td>YAGI_AML_WITH_11Q23_REARRANGED</td><td></td><td>24</td><td>0.39</td><td>1.19</td><td>0.192</td><td>0.575</td><td>1.000</td><td>384</td><td>tags=50%, list=34%, signal=74%</td></tr><tr><td class='lessen'>147</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP</td><td></td><td>26</td><td>0.39</td><td>1.19</td><td>0.194</td><td>0.577</td><td>1.000</td><td>421</td><td>tags=54%, list=37%, signal=83%</td></tr><tr><td class='lessen'>148</td><td>REACTOME_METABOLISM_OF_RNA</td><td></td><td>24</td><td>0.39</td><td>1.19</td><td>0.209</td><td>0.575</td><td>1.000</td><td>285</td><td>tags=46%, list=25%, signal=60%</td></tr><tr><td class='lessen'>149</td><td>FOURNIER_ACINAR_DEVELOPMENT_LATE_2</td><td></td><td>15</td><td>0.43</td><td>1.19</td><td>0.215</td><td>0.574</td><td>1.000</td><td>312</td><td>tags=47%, list=27%, signal=63%</td></tr><tr><td class='lessen'>150</td><td>BENPORATH_PRC2_TARGETS</td><td></td><td>22</td><td>0.40</td><td>1.19</td><td>0.209</td><td>0.572</td><td>1.000</td><td>292</td><td>tags=41%, list=26%, signal=54%</td></tr><tr><td class='lessen'>151</td><td>SMID_BREAST_CANCER_BASAL_DN</td><td></td><td>41</td><td>0.36</td><td>1.18</td><td>0.180</td><td>0.576</td><td>1.000</td><td>591</td><td>tags=71%, list=52%, signal=141%</td></tr><tr><td class='lessen'>152</td><td>REACTOME_SIGNALING_BY_GPCR</td><td></td><td>66</td><td>0.34</td><td>1.18</td><td>0.155</td><td>0.600</td><td>1.000</td><td>373</td><td>tags=44%, list=33%, signal=61%</td></tr><tr><td class='lessen'>153</td><td>BENPORATH_EED_TARGETS</td><td></td><td>39</td><td>0.36</td><td>1.17</td><td>0.177</td><td>0.601</td><td>1.000</td><td>367</td><td>tags=41%, list=32%, signal=58%</td></tr><tr><td class='lessen'>154</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2</td><td></td><td>25</td><td>0.38</td><td>1.17</td><td>0.214</td><td>0.612</td><td>1.000</td><td>413</td><td>tags=44%, list=36%, signal=67%</td></tr><tr><td class='lessen'>155</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3</td><td></td><td>40</td><td>0.36</td><td>1.17</td><td>0.202</td><td>0.614</td><td>1.000</td><td>604</td><td>tags=70%, list=53%, signal=143%</td></tr><tr><td class='lessen'>156</td><td>MARTINEZ_TP53_TARGETS_UP</td><td></td><td>45</td><td>0.35</td><td>1.17</td><td>0.173</td><td>0.612</td><td>1.000</td><td>540</td><td>tags=62%, list=47%, signal=113%</td></tr><tr><td class='lessen'>157</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME2</td><td></td><td>29</td><td>0.37</td><td>1.17</td><td>0.204</td><td>0.614</td><td>1.000</td><td>402</td><td>tags=52%, list=35%, signal=78%</td></tr><tr><td class='lessen'>158</td><td>ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN</td><td></td><td>23</td><td>0.38</td><td>1.16</td><td>0.233</td><td>0.624</td><td>1.000</td><td>515</td><td>tags=57%, list=45%, signal=101%</td></tr><tr><td class='lessen'>159</td><td>ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP</td><td></td><td>16</td><td>0.41</td><td>1.16</td><td>0.262</td><td>0.622</td><td>1.000</td><td>313</td><td>tags=44%, list=27%, signal=59%</td></tr><tr><td class='lessen'>160</td><td>REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS</td><td></td><td>17</td><td>0.40</td><td>1.16</td><td>0.246</td><td>0.620</td><td>1.000</td><td>576</td><td>tags=76%, list=50%, signal=152%</td></tr><tr><td class='lessen'>161</td><td>IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR</td><td></td><td>23</td><td>0.39</td><td>1.16</td><td>0.224</td><td>0.618</td><td>1.000</td><td>202</td><td>tags=35%, list=18%, signal=41%</td></tr><tr><td class='lessen'>162</td><td>PUJANA_ATM_PCC_NETWORK</td><td></td><td>70</td><td>0.34</td><td>1.16</td><td>0.166</td><td>0.614</td><td>1.000</td><td>364</td><td>tags=43%, list=32%, signal=59%</td></tr><tr><td class='lessen'>163</td><td>HATADA_METHYLATED_IN_LUNG_CANCER_UP</td><td></td><td>21</td><td>0.39</td><td>1.16</td><td>0.239</td><td>0.616</td><td>1.000</td><td>529</td><td>tags=67%, list=46%, signal=122%</td></tr><tr><td class='lessen'>164</td><td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP</td><td></td><td>39</td><td>0.36</td><td>1.16</td><td>0.207</td><td>0.617</td><td>1.000</td><td>421</td><td>tags=49%, list=37%, signal=74%</td></tr><tr><td class='lessen'>165</td><td>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP</td><td></td><td>61</td><td>0.34</td><td>1.16</td><td>0.173</td><td>0.621</td><td>1.000</td><td>385</td><td>tags=44%, list=34%, signal=63%</td></tr><tr><td class='lessen'>166</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN</td><td></td><td>23</td><td>0.38</td><td>1.15</td><td>0.254</td><td>0.621</td><td>1.000</td><td>604</td><td>tags=74%, list=53%, signal=153%</td></tr><tr><td class='lessen'>167</td><td>SENESE_HDAC1_AND_HDAC2_TARGETS_DN</td><td></td><td>15</td><td>0.41</td><td>1.15</td><td>0.268</td><td>0.621</td><td>1.000</td><td>599</td><td>tags=73%, list=52%, signal=152%</td></tr><tr><td class='lessen'>168</td><td>REACTOME_SIGNALING_BY_WNT</td><td></td><td>15</td><td>0.41</td><td>1.15</td><td>0.255</td><td>0.622</td><td>1.000</td><td>459</td><td>tags=60%, list=40%, signal=99%</td></tr><tr><td class='lessen'>169</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN</td><td></td><td>18</td><td>0.40</td><td>1.15</td><td>0.252</td><td>0.621</td><td>1.000</td><td>343</td><td>tags=50%, list=30%, signal=70%</td></tr><tr><td class='lessen'>170</td><td>SHEN_SMARCA2_TARGETS_UP</td><td></td><td>17</td><td>0.40</td><td>1.15</td><td>0.266</td><td>0.617</td><td>1.000</td><td>386</td><td>tags=53%, list=34%, signal=79%</td></tr><tr><td class='lessen'>171</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>24</td><td>0.38</td><td>1.15</td><td>0.247</td><td>0.627</td><td>1.000</td><td>453</td><td>tags=58%, list=40%, signal=94%</td></tr><tr><td class='lessen'>172</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR</td><td></td><td>27</td><td>0.37</td><td>1.15</td><td>0.245</td><td>0.624</td><td>1.000</td><td>597</td><td>tags=67%, list=52%, signal=136%</td></tr><tr><td class='lessen'>173</td><td>CHICAS_RB1_TARGETS_SENESCENT</td><td></td><td>22</td><td>0.38</td><td>1.15</td><td>0.265</td><td>0.622</td><td>1.000</td><td>289</td><td>tags=41%, list=25%, signal=54%</td></tr><tr><td class='lessen'>174</td><td>BOCHKIS_FOXA2_TARGETS</td><td></td><td>26</td><td>0.37</td><td>1.15</td><td>0.260</td><td>0.619</td><td>1.000</td><td>396</td><td>tags=46%, list=35%, signal=69%</td></tr><tr><td class='lessen'>175</td><td>CUI_TCF21_TARGETS_2_DN</td><td></td><td>38</td><td>0.35</td><td>1.14</td><td>0.237</td><td>0.624</td><td>1.000</td><td>526</td><td>tags=58%, list=46%, signal=104%</td></tr><tr><td class='lessen'>176</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP</td><td></td><td>22</td><td>0.38</td><td>1.14</td><td>0.247</td><td>0.624</td><td>1.000</td><td>563</td><td>tags=64%, list=49%, signal=123%</td></tr><tr><td class='lessen'>177</td><td>WANG_SMARCE1_TARGETS_UP</td><td></td><td>17</td><td>0.40</td><td>1.14</td><td>0.280</td><td>0.621</td><td>1.000</td><td>576</td><td>tags=76%, list=50%, signal=152%</td></tr><tr><td class='lessen'>178</td><td>ZHENG_GLIOBLASTOMA_PLASTICITY_UP</td><td></td><td>15</td><td>0.41</td><td>1.14</td><td>0.277</td><td>0.619</td><td>1.000</td><td>650</td><td>tags=87%, list=57%, signal=198%</td></tr><tr><td class='lessen'>179</td><td>GAL_LEUKEMIC_STEM_CELL_DN</td><td></td><td>18</td><td>0.39</td><td>1.14</td><td>0.262</td><td>0.617</td><td>1.000</td><td>168</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>180</td><td>BLALOCK_ALZHEIMERS_DISEASE_DN</td><td></td><td>57</td><td>0.34</td><td>1.14</td><td>0.196</td><td>0.618</td><td>1.000</td><td>602</td><td>tags=68%, list=53%, signal=137%</td></tr><tr><td class='lessen'>181</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_1_DN</td><td></td><td>24</td><td>0.37</td><td>1.14</td><td>0.273</td><td>0.623</td><td>1.000</td><td>494</td><td>tags=63%, list=43%, signal=108%</td></tr><tr><td class='lessen'>182</td><td>REACTOME_NERVOUS_SYSTEM_DEVELOPMENT</td><td></td><td>28</td><td>0.37</td><td>1.14</td><td>0.249</td><td>0.620</td><td>1.000</td><td>371</td><td>tags=39%, list=32%, signal=57%</td></tr><tr><td class='lessen'>183</td><td>REACTOME_SIGNALING_BY_INTERLEUKINS</td><td></td><td>36</td><td>0.35</td><td>1.14</td><td>0.229</td><td>0.623</td><td>1.000</td><td>576</td><td>tags=64%, list=50%, signal=125%</td></tr><tr><td class='lessen'>184</td><td>FEVR_CTNNB1_TARGETS_UP</td><td></td><td>48</td><td>0.34</td><td>1.13</td><td>0.222</td><td>0.629</td><td>1.000</td><td>515</td><td>tags=58%, list=45%, signal=102%</td></tr><tr><td class='lessen'>185</td><td>SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1</td><td></td><td>34</td><td>0.35</td><td>1.13</td><td>0.265</td><td>0.632</td><td>1.000</td><td>580</td><td>tags=65%, list=51%, signal=127%</td></tr><tr><td class='lessen'>186</td><td>BROWNE_HCMV_INFECTION_24HR_DN</td><td></td><td>15</td><td>0.40</td><td>1.13</td><td>0.288</td><td>0.640</td><td>1.000</td><td>108</td><td>tags=27%, list=9%, signal=29%</td></tr><tr><td class='lessen'>187</td><td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN</td><td></td><td>17</td><td>0.39</td><td>1.13</td><td>0.291</td><td>0.645</td><td>1.000</td><td>98</td><td>tags=24%, list=9%, signal=25%</td></tr><tr><td class='lessen'>188</td><td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP</td><td></td><td>16</td><td>0.39</td><td>1.12</td><td>0.302</td><td>0.647</td><td>1.000</td><td>702</td><td>tags=100%, list=61%, signal=255%</td></tr><tr><td class='lessen'>189</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_2B</td><td></td><td>21</td><td>0.38</td><td>1.12</td><td>0.289</td><td>0.651</td><td>1.000</td><td>481</td><td>tags=62%, list=42%, signal=105%</td></tr><tr><td class='lessen'>190</td><td>SWEET_LUNG_CANCER_KRAS_DN</td><td></td><td>29</td><td>0.36</td><td>1.12</td><td>0.292</td><td>0.662</td><td>1.000</td><td>563</td><td>tags=66%, list=49%, signal=126%</td></tr><tr><td class='lessen'>191</td><td>REACTOME_DEVELOPMENTAL_BIOLOGY</td><td></td><td>61</td><td>0.33</td><td>1.12</td><td>0.236</td><td>0.660</td><td>1.000</td><td>371</td><td>tags=41%, list=32%, signal=57%</td></tr><tr><td class='lessen'>192</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_UP</td><td></td><td>19</td><td>0.38</td><td>1.12</td><td>0.322</td><td>0.657</td><td>1.000</td><td>488</td><td>tags=58%, list=43%, signal=99%</td></tr><tr><td class='lessen'>193</td><td>KEGG_TIGHT_JUNCTION</td><td></td><td>15</td><td>0.40</td><td>1.12</td><td>0.327</td><td>0.658</td><td>1.000</td><td>515</td><td>tags=67%, list=45%, signal=120%</td></tr><tr><td class='lessen'>194</td><td>DAZARD_RESPONSE_TO_UV_NHEK_UP</td><td></td><td>17</td><td>0.38</td><td>1.12</td><td>0.313</td><td>0.658</td><td>1.000</td><td>488</td><td>tags=59%, list=43%, signal=101%</td></tr><tr><td class='lessen'>195</td><td>RICKMAN_METASTASIS_DN</td><td></td><td>24</td><td>0.37</td><td>1.12</td><td>0.317</td><td>0.655</td><td>1.000</td><td>624</td><td>tags=79%, list=54%, signal=170%</td></tr><tr><td class='lessen'>196</td><td>HAN_SATB1_TARGETS_DN</td><td></td><td>23</td><td>0.37</td><td>1.12</td><td>0.294</td><td>0.653</td><td>1.000</td><td>376</td><td>tags=43%, list=33%, signal=63%</td></tr><tr><td class='lessen'>197</td><td>ENK_UV_RESPONSE_KERATINOCYTE_UP</td><td></td><td>31</td><td>0.35</td><td>1.11</td><td>0.292</td><td>0.663</td><td>1.000</td><td>295</td><td>tags=39%, list=26%, signal=51%</td></tr><tr><td class='lessen'>198</td><td>KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3</td><td></td><td>43</td><td>0.34</td><td>1.11</td><td>0.283</td><td>0.670</td><td>1.000</td><td>549</td><td>tags=63%, list=48%, signal=116%</td></tr><tr><td class='lessen'>199</td><td>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</td><td></td><td>37</td><td>0.34</td><td>1.11</td><td>0.282</td><td>0.668</td><td>1.000</td><td>580</td><td>tags=68%, list=51%, signal=133%</td></tr><tr><td class='lessen'>200</td><td>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</td><td></td><td>20</td><td>0.38</td><td>1.11</td><td>0.321</td><td>0.665</td><td>1.000</td><td>438</td><td>tags=45%, list=38%, signal=72%</td></tr><tr><td class='lessen'>201</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>18</td><td>0.38</td><td>1.11</td><td>0.329</td><td>0.663</td><td>1.000</td><td>377</td><td>tags=44%, list=33%, signal=65%</td></tr><tr><td class='lessen'>202</td><td>DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP</td><td></td><td>55</td><td>0.33</td><td>1.11</td><td>0.268</td><td>0.663</td><td>1.000</td><td>567</td><td>tags=62%, list=50%, signal=117%</td></tr><tr><td class='lessen'>203</td><td>GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS</td><td></td><td>55</td><td>0.33</td><td>1.11</td><td>0.280</td><td>0.662</td><td>1.000</td><td>352</td><td>tags=40%, list=31%, signal=55%</td></tr><tr><td class='lessen'>204</td><td>BLALOCK_ALZHEIMERS_DISEASE_UP</td><td></td><td>91</td><td>0.32</td><td>1.10</td><td>0.242</td><td>0.664</td><td>1.000</td><td>385</td><td>tags=42%, list=34%, signal=58%</td></tr><tr><td class='lessen'>205</td><td>BASAKI_YBX1_TARGETS_UP</td><td></td><td>19</td><td>0.37</td><td>1.10</td><td>0.314</td><td>0.662</td><td>1.000</td><td>123</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>206</td><td>KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP</td><td></td><td>41</td><td>0.34</td><td>1.10</td><td>0.298</td><td>0.659</td><td>1.000</td><td>395</td><td>tags=44%, list=34%, signal=65%</td></tr><tr><td class='lessen'>207</td><td>REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI</td><td></td><td>29</td><td>0.35</td><td>1.10</td><td>0.319</td><td>0.662</td><td>1.000</td><td>499</td><td>tags=52%, list=44%, signal=89%</td></tr><tr><td class='lessen'>208</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP</td><td></td><td>21</td><td>0.36</td><td>1.10</td><td>0.323</td><td>0.664</td><td>1.000</td><td>492</td><td>tags=57%, list=43%, signal=98%</td></tr><tr><td class='lessen'>209</td><td>MULLIGHAN_MLL_SIGNATURE_1_UP</td><td></td><td>19</td><td>0.38</td><td>1.10</td><td>0.331</td><td>0.669</td><td>1.000</td><td>668</td><td>tags=89%, list=58%, signal=211%</td></tr><tr><td class='lessen'>210</td><td>OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP</td><td></td><td>16</td><td>0.38</td><td>1.10</td><td>0.354</td><td>0.671</td><td>1.000</td><td>346</td><td>tags=44%, list=30%, signal=62%</td></tr><tr><td class='lessen'>211</td><td>IVANOVA_HEMATOPOIESIS_MATURE_CELL</td><td></td><td>15</td><td>0.39</td><td>1.09</td><td>0.330</td><td>0.675</td><td>1.000</td><td>500</td><td>tags=67%, list=44%, signal=117%</td></tr><tr><td class='lessen'>212</td><td>MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>64</td><td>0.32</td><td>1.09</td><td>0.290</td><td>0.674</td><td>1.000</td><td>624</td><td>tags=67%, list=54%, signal=139%</td></tr><tr><td class='lessen'>213</td><td>PARENT_MTOR_SIGNALING_UP</td><td></td><td>22</td><td>0.37</td><td>1.09</td><td>0.339</td><td>0.674</td><td>1.000</td><td>668</td><td>tags=82%, list=58%, signal=193%</td></tr><tr><td class='lessen'>214</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN</td><td></td><td>25</td><td>0.35</td><td>1.09</td><td>0.335</td><td>0.673</td><td>1.000</td><td>411</td><td>tags=48%, list=36%, signal=73%</td></tr><tr><td class='lessen'>215</td><td>SENESE_HDAC3_TARGETS_UP</td><td></td><td>24</td><td>0.36</td><td>1.09</td><td>0.335</td><td>0.681</td><td>1.000</td><td>141</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>216</td><td>REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM</td><td></td><td>57</td><td>0.32</td><td>1.08</td><td>0.315</td><td>0.696</td><td>1.000</td><td>576</td><td>tags=58%, list=50%, signal=111%</td></tr><tr><td class='lessen'>217</td><td>MULLIGHAN_NPM1_SIGNATURE_3_UP</td><td></td><td>18</td><td>0.37</td><td>1.08</td><td>0.353</td><td>0.693</td><td>1.000</td><td>365</td><td>tags=44%, list=32%, signal=64%</td></tr><tr><td class='lessen'>218</td><td>ZHANG_BREAST_CANCER_PROGENITORS_UP</td><td></td><td>16</td><td>0.38</td><td>1.08</td><td>0.369</td><td>0.700</td><td>1.000</td><td>496</td><td>tags=63%, list=43%, signal=109%</td></tr><tr><td class='lessen'>219</td><td>BAELDE_DIABETIC_NEPHROPATHY_DN</td><td></td><td>16</td><td>0.38</td><td>1.08</td><td>0.373</td><td>0.700</td><td>1.000</td><td>590</td><td>tags=69%, list=52%, signal=140%</td></tr><tr><td class='lessen'>220</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_UP</td><td></td><td>17</td><td>0.37</td><td>1.08</td><td>0.367</td><td>0.697</td><td>1.000</td><td>332</td><td>tags=47%, list=29%, signal=65%</td></tr><tr><td class='lessen'>221</td><td>MARTINEZ_RB1_TARGETS_DN</td><td></td><td>39</td><td>0.33</td><td>1.08</td><td>0.345</td><td>0.702</td><td>1.000</td><td>388</td><td>tags=44%, list=34%, signal=64%</td></tr><tr><td class='lessen'>222</td><td>MARKEY_RB1_ACUTE_LOF_DN</td><td></td><td>16</td><td>0.38</td><td>1.07</td><td>0.371</td><td>0.712</td><td>1.000</td><td>444</td><td>tags=56%, list=39%, signal=91%</td></tr><tr><td class='lessen'>223</td><td>PEDRIOLI_MIR31_TARGETS_DN</td><td></td><td>23</td><td>0.35</td><td>1.07</td><td>0.392</td><td>0.725</td><td>1.000</td><td>490</td><td>tags=61%, list=43%, signal=104%</td></tr><tr><td class='lessen'>224</td><td>REACTOME_DISEASE</td><td></td><td>74</td><td>0.31</td><td>1.06</td><td>0.337</td><td>0.728</td><td>1.000</td><td>359</td><td>tags=38%, list=31%, signal=52%</td></tr><tr><td class='lessen'>225</td><td>WEI_MYCN_TARGETS_WITH_E_BOX</td><td></td><td>24</td><td>0.36</td><td>1.06</td><td>0.368</td><td>0.735</td><td>1.000</td><td>333</td><td>tags=38%, list=29%, signal=52%</td></tr><tr><td class='lessen'>226</td><td>MOHANKUMAR_HOXA1_TARGETS_DN</td><td></td><td>15</td><td>0.37</td><td>1.06</td><td>0.417</td><td>0.745</td><td>1.000</td><td>539</td><td>tags=67%, list=47%, signal=124%</td></tr><tr><td class='lessen'>227</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP</td><td></td><td>20</td><td>0.35</td><td>1.05</td><td>0.403</td><td>0.751</td><td>1.000</td><td>512</td><td>tags=60%, list=45%, signal=107%</td></tr><tr><td class='lessen'>228</td><td>SMID_BREAST_CANCER_BASAL_UP</td><td></td><td>41</td><td>0.33</td><td>1.05</td><td>0.363</td><td>0.751</td><td>1.000</td><td>243</td><td>tags=32%, list=21%, signal=39%</td></tr><tr><td class='lessen'>229</td><td>MULLIGHAN_MLL_SIGNATURE_2_UP</td><td></td><td>22</td><td>0.35</td><td>1.05</td><td>0.419</td><td>0.760</td><td>1.000</td><td>668</td><td>tags=77%, list=58%, signal=182%</td></tr><tr><td class='lessen'>230</td><td>REACTOME_MAPK_FAMILY_SIGNALING_CASCADES</td><td></td><td>23</td><td>0.35</td><td>1.05</td><td>0.417</td><td>0.766</td><td>1.000</td><td>576</td><td>tags=57%, list=50%, signal=111%</td></tr><tr><td class='lessen'>231</td><td>REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS</td><td></td><td>16</td><td>0.37</td><td>1.05</td><td>0.405</td><td>0.767</td><td>1.000</td><td>291</td><td>tags=38%, list=25%, signal=50%</td></tr><tr><td class='lessen'>232</td><td>MARTINEZ_TP53_TARGETS_DN</td><td></td><td>39</td><td>0.32</td><td>1.04</td><td>0.396</td><td>0.767</td><td>1.000</td><td>680</td><td>tags=74%, list=59%, signal=177%</td></tr><tr><td class='lessen'>233</td><td>HOLLERN_SQUAMOUS_BREAST_TUMOR</td><td></td><td>19</td><td>0.35</td><td>1.04</td><td>0.417</td><td>0.771</td><td>1.000</td><td>239</td><td>tags=37%, list=21%, signal=46%</td></tr><tr><td class='lessen'>234</td><td>ODONNELL_TFRC_TARGETS_UP</td><td></td><td>23</td><td>0.35</td><td>1.04</td><td>0.430</td><td>0.770</td><td>1.000</td><td>689</td><td>tags=83%, list=60%, signal=203%</td></tr><tr><td class='lessen'>235</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP</td><td></td><td>22</td><td>0.35</td><td>1.04</td><td>0.424</td><td>0.768</td><td>1.000</td><td>142</td><td>tags=27%, list=12%, signal=31%</td></tr><tr><td class='lessen'>236</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP</td><td></td><td>19</td><td>0.36</td><td>1.04</td><td>0.420</td><td>0.782</td><td>1.000</td><td>453</td><td>tags=47%, list=40%, signal=77%</td></tr><tr><td class='lessen'>237</td><td>SCHLOSSER_SERUM_RESPONSE_DN</td><td></td><td>40</td><td>0.32</td><td>1.03</td><td>0.433</td><td>0.782</td><td>1.000</td><td>353</td><td>tags=40%, list=31%, signal=56%</td></tr><tr><td class='lessen'>238</td><td>KEGG_FOCAL_ADHESION</td><td></td><td>19</td><td>0.36</td><td>1.03</td><td>0.443</td><td>0.787</td><td>1.000</td><td>270</td><td>tags=32%, list=24%, signal=41%</td></tr><tr><td class='lessen'>239</td><td>LEE_BMP2_TARGETS_DN</td><td></td><td>32</td><td>0.32</td><td>1.03</td><td>0.431</td><td>0.791</td><td>1.000</td><td>400</td><td>tags=44%, list=35%, signal=65%</td></tr><tr><td class='lessen'>240</td><td>FORTSCHEGGER_PHF8_TARGETS_DN</td><td></td><td>43</td><td>0.31</td><td>1.03</td><td>0.423</td><td>0.788</td><td>1.000</td><td>620</td><td>tags=65%, list=54%, signal=137%</td></tr><tr><td class='lessen'>241</td><td>REACTOME_KERATINIZATION</td><td></td><td>15</td><td>0.37</td><td>1.03</td><td>0.445</td><td>0.787</td><td>1.000</td><td>165</td><td>tags=27%, list=14%, signal=31%</td></tr><tr><td class='lessen'>242</td><td>JAATINEN_HEMATOPOIETIC_STEM_CELL_DN</td><td></td><td>15</td><td>0.37</td><td>1.03</td><td>0.442</td><td>0.786</td><td>1.000</td><td>217</td><td>tags=27%, list=19%, signal=32%</td></tr><tr><td class='lessen'>243</td><td>ONDER_CDH1_TARGETS_2_DN</td><td></td><td>33</td><td>0.32</td><td>1.02</td><td>0.447</td><td>0.803</td><td>1.000</td><td>538</td><td>tags=58%, list=47%, signal=105%</td></tr><tr><td class='lessen'>244</td><td>BENPORATH_ES_WITH_H3K27ME3</td><td></td><td>46</td><td>0.31</td><td>1.02</td><td>0.460</td><td>0.800</td><td>1.000</td><td>203</td><td>tags=26%, list=18%, signal=30%</td></tr><tr><td class='lessen'>245</td><td>REACTOME_SIGNALING_BY_RHO_GTPASES</td><td></td><td>26</td><td>0.33</td><td>1.02</td><td>0.467</td><td>0.797</td><td>1.000</td><td>442</td><td>tags=46%, list=39%, signal=73%</td></tr><tr><td class='lessen'>246</td><td>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP</td><td></td><td>15</td><td>0.37</td><td>1.02</td><td>0.463</td><td>0.795</td><td>1.000</td><td>453</td><td>tags=47%, list=40%, signal=76%</td></tr><tr><td class='lessen'>247</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN</td><td></td><td>31</td><td>0.33</td><td>1.02</td><td>0.457</td><td>0.802</td><td>1.000</td><td>460</td><td>tags=52%, list=40%, signal=84%</td></tr><tr><td class='lessen'>248</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP</td><td></td><td>18</td><td>0.35</td><td>1.02</td><td>0.457</td><td>0.802</td><td>1.000</td><td>525</td><td>tags=67%, list=46%, signal=121%</td></tr><tr><td class='lessen'>249</td><td>MCBRYAN_PUBERTAL_BREAST_4_5WK_UP</td><td></td><td>16</td><td>0.36</td><td>1.02</td><td>0.461</td><td>0.802</td><td>1.000</td><td>578</td><td>tags=69%, list=50%, signal=137%</td></tr><tr><td class='lessen'>250</td><td>CAIRO_HEPATOBLASTOMA_DN</td><td></td><td>20</td><td>0.35</td><td>1.01</td><td>0.477</td><td>0.807</td><td>1.000</td><td>320</td><td>tags=35%, list=28%, signal=48%</td></tr><tr><td class='lessen'>251</td><td>REACTOME_PHOSPHOLIPID_METABOLISM</td><td></td><td>22</td><td>0.34</td><td>1.01</td><td>0.472</td><td>0.805</td><td>1.000</td><td>433</td><td>tags=45%, list=38%, signal=72%</td></tr><tr><td class='lessen'>252</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN</td><td></td><td>22</td><td>0.34</td><td>1.01</td><td>0.467</td><td>0.803</td><td>1.000</td><td>238</td><td>tags=32%, list=21%, signal=39%</td></tr><tr><td class='lessen'>253</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP</td><td></td><td>27</td><td>0.32</td><td>1.01</td><td>0.456</td><td>0.804</td><td>1.000</td><td>620</td><td>tags=70%, list=54%, signal=150%</td></tr><tr><td class='lessen'>254</td><td>MOOTHA_PGC</td><td></td><td>20</td><td>0.34</td><td>1.01</td><td>0.464</td><td>0.803</td><td>1.000</td><td>517</td><td>tags=60%, list=45%, signal=107%</td></tr><tr><td class='lessen'>255</td><td>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN</td><td></td><td>24</td><td>0.33</td><td>1.01</td><td>0.484</td><td>0.806</td><td>1.000</td><td>712</td><td>tags=79%, list=62%, signal=205%</td></tr><tr><td class='lessen'>256</td><td>SANSOM_APC_TARGETS</td><td></td><td>18</td><td>0.35</td><td>1.01</td><td>0.471</td><td>0.806</td><td>1.000</td><td>689</td><td>tags=83%, list=60%, signal=206%</td></tr><tr><td class='lessen'>257</td><td>HELLER_SILENCED_BY_METHYLATION_UP</td><td></td><td>17</td><td>0.35</td><td>1.01</td><td>0.469</td><td>0.803</td><td>1.000</td><td>639</td><td>tags=71%, list=56%, signal=157%</td></tr><tr><td class='lessen'>258</td><td>FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP</td><td></td><td>25</td><td>0.33</td><td>1.01</td><td>0.477</td><td>0.806</td><td>1.000</td><td>373</td><td>tags=40%, list=33%, signal=58%</td></tr><tr><td class='lessen'>259</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN</td><td></td><td>15</td><td>0.36</td><td>1.00</td><td>0.484</td><td>0.807</td><td>1.000</td><td>633</td><td>tags=73%, list=55%, signal=162%</td></tr><tr><td class='lessen'>260</td><td>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</td><td></td><td>15</td><td>0.35</td><td>1.00</td><td>0.483</td><td>0.806</td><td>1.000</td><td>171</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>261</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_DN</td><td></td><td>37</td><td>0.31</td><td>1.00</td><td>0.494</td><td>0.806</td><td>1.000</td><td>680</td><td>tags=73%, list=59%, signal=174%</td></tr><tr><td class='lessen'>262</td><td>BOQUEST_STEM_CELL_DN</td><td></td><td>18</td><td>0.34</td><td>1.00</td><td>0.492</td><td>0.805</td><td>1.000</td><td>305</td><td>tags=39%, list=27%, signal=52%</td></tr><tr><td class='lessen'>263</td><td>LI_INDUCED_T_TO_NATURAL_KILLER_UP</td><td></td><td>21</td><td>0.33</td><td>1.00</td><td>0.512</td><td>0.817</td><td>1.000</td><td>311</td><td>tags=33%, list=27%, signal=45%</td></tr><tr><td class='lessen'>264</td><td>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP</td><td></td><td>35</td><td>0.31</td><td>0.99</td><td>0.505</td><td>0.824</td><td>1.000</td><td>542</td><td>tags=57%, list=47%, signal=105%</td></tr><tr><td class='lessen'>265</td><td>CHEN_METABOLIC_SYNDROM_NETWORK</td><td></td><td>80</td><td>0.29</td><td>0.99</td><td>0.540</td><td>0.839</td><td>1.000</td><td>677</td><td>tags=66%, list=59%, signal=151%</td></tr><tr><td class='lessen'>266</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_UP</td><td></td><td>18</td><td>0.34</td><td>0.99</td><td>0.491</td><td>0.839</td><td>1.000</td><td>374</td><td>tags=44%, list=33%, signal=65%</td></tr><tr><td class='lessen'>267</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B</td><td></td><td>34</td><td>0.31</td><td>0.98</td><td>0.517</td><td>0.842</td><td>1.000</td><td>443</td><td>tags=47%, list=39%, signal=74%</td></tr><tr><td class='lessen'>268</td><td>REACTOME_NEUTROPHIL_DEGRANULATION</td><td></td><td>28</td><td>0.32</td><td>0.98</td><td>0.526</td><td>0.840</td><td>1.000</td><td>239</td><td>tags=29%, list=21%, signal=35%</td></tr><tr><td class='lessen'>269</td><td>WONG_ADULT_TISSUE_STEM_MODULE</td><td></td><td>39</td><td>0.31</td><td>0.98</td><td>0.542</td><td>0.837</td><td>1.000</td><td>376</td><td>tags=38%, list=33%, signal=55%</td></tr><tr><td class='lessen'>270</td><td>RIGGINS_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>16</td><td>0.34</td><td>0.98</td><td>0.534</td><td>0.837</td><td>1.000</td><td>563</td><td>tags=63%, list=49%, signal=121%</td></tr><tr><td class='lessen'>271</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12</td><td></td><td>18</td><td>0.34</td><td>0.98</td><td>0.515</td><td>0.835</td><td>1.000</td><td>524</td><td>tags=50%, list=46%, signal=91%</td></tr><tr><td class='lessen'>272</td><td>LU_EZH2_TARGETS_UP</td><td></td><td>16</td><td>0.35</td><td>0.98</td><td>0.512</td><td>0.851</td><td>1.000</td><td>314</td><td>tags=38%, list=27%, signal=51%</td></tr><tr><td class='lessen'>273</td><td>REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES</td><td></td><td>25</td><td>0.32</td><td>0.97</td><td>0.538</td><td>0.857</td><td>1.000</td><td>336</td><td>tags=36%, list=29%, signal=50%</td></tr><tr><td class='lessen'>274</td><td>KRIEG_HYPOXIA_NOT_VIA_KDM3A</td><td></td><td>37</td><td>0.30</td><td>0.97</td><td>0.545</td><td>0.859</td><td>1.000</td><td>236</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>275</td><td>GARY_CD5_TARGETS_UP</td><td></td><td>20</td><td>0.33</td><td>0.97</td><td>0.543</td><td>0.856</td><td>1.000</td><td>312</td><td>tags=35%, list=27%, signal=47%</td></tr><tr><td class='lessen'>276</td><td>REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION</td><td></td><td>71</td><td>0.28</td><td>0.97</td><td>0.580</td><td>0.854</td><td>1.000</td><td>569</td><td>tags=54%, list=50%, signal=100%</td></tr><tr><td class='lessen'>277</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5</td><td></td><td>22</td><td>0.32</td><td>0.97</td><td>0.559</td><td>0.862</td><td>1.000</td><td>748</td><td>tags=91%, list=65%, signal=257%</td></tr><tr><td class='lessen'>278</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN</td><td></td><td>23</td><td>0.32</td><td>0.96</td><td>0.567</td><td>0.867</td><td>1.000</td><td>313</td><td>tags=35%, list=27%, signal=47%</td></tr><tr><td class='lessen'>279</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_DN</td><td></td><td>26</td><td>0.32</td><td>0.96</td><td>0.541</td><td>0.864</td><td>1.000</td><td>395</td><td>tags=42%, list=34%, signal=63%</td></tr><tr><td class='lessen'>280</td><td>KEGG_CHEMOKINE_SIGNALING_PATHWAY</td><td></td><td>16</td><td>0.34</td><td>0.96</td><td>0.559</td><td>0.866</td><td>1.000</td><td>153</td><td>tags=25%, list=13%, signal=28%</td></tr><tr><td class='lessen'>281</td><td>JOHNSTONE_PARVB_TARGETS_2_DN</td><td></td><td>20</td><td>0.32</td><td>0.96</td><td>0.544</td><td>0.867</td><td>1.000</td><td>376</td><td>tags=40%, list=33%, signal=59%</td></tr><tr><td class='lessen'>282</td><td>REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION</td><td></td><td>23</td><td>0.32</td><td>0.96</td><td>0.557</td><td>0.867</td><td>1.000</td><td>569</td><td>tags=57%, list=50%, signal=110%</td></tr><tr><td class='lessen'>283</td><td>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</td><td></td><td>19</td><td>0.32</td><td>0.96</td><td>0.558</td><td>0.865</td><td>1.000</td><td>728</td><td>tags=79%, list=64%, signal=213%</td></tr><tr><td class='lessen'>284</td><td>PEREZ_TP53_TARGETS</td><td></td><td>70</td><td>0.28</td><td>0.96</td><td>0.618</td><td>0.869</td><td>1.000</td><td>222</td><td>tags=26%, list=19%, signal=30%</td></tr><tr><td class='lessen'>285</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN</td><td></td><td>27</td><td>0.31</td><td>0.95</td><td>0.571</td><td>0.873</td><td>1.000</td><td>563</td><td>tags=56%, list=49%, signal=107%</td></tr><tr><td class='lessen'>286</td><td>CAIRO_HEPATOBLASTOMA_CLASSES_DN</td><td></td><td>15</td><td>0.34</td><td>0.95</td><td>0.578</td><td>0.873</td><td>1.000</td><td>711</td><td>tags=87%, list=62%, signal=226%</td></tr><tr><td class='lessen'>287</td><td>REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS</td><td></td><td>15</td><td>0.34</td><td>0.95</td><td>0.553</td><td>0.870</td><td>1.000</td><td>198</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>288</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN</td><td></td><td>28</td><td>0.30</td><td>0.95</td><td>0.562</td><td>0.869</td><td>1.000</td><td>702</td><td>tags=75%, list=61%, signal=189%</td></tr><tr><td class='lessen'>289</td><td>REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS</td><td></td><td>30</td><td>0.30</td><td>0.95</td><td>0.568</td><td>0.867</td><td>1.000</td><td>467</td><td>tags=47%, list=41%, signal=77%</td></tr><tr><td class='lessen'>290</td><td>LEI_MYB_TARGETS</td><td></td><td>20</td><td>0.32</td><td>0.95</td><td>0.584</td><td>0.867</td><td>1.000</td><td>453</td><td>tags=55%, list=40%, signal=89%</td></tr><tr><td class='lessen'>291</td><td>CHYLA_CBFA2T3_TARGETS_UP</td><td></td><td>20</td><td>0.32</td><td>0.95</td><td>0.573</td><td>0.865</td><td>1.000</td><td>485</td><td>tags=45%, list=42%, signal=77%</td></tr><tr><td class='lessen'>292</td><td>REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT</td><td></td><td>15</td><td>0.33</td><td>0.95</td><td>0.563</td><td>0.868</td><td>1.000</td><td>569</td><td>tags=53%, list=50%, signal=105%</td></tr><tr><td class='lessen'>293</td><td>SMID_BREAST_CANCER_LUMINAL_B_DN</td><td></td><td>43</td><td>0.29</td><td>0.95</td><td>0.592</td><td>0.871</td><td>1.000</td><td>540</td><td>tags=49%, list=47%, signal=89%</td></tr><tr><td class='lessen'>294</td><td>WINTER_HYPOXIA_METAGENE</td><td></td><td>17</td><td>0.33</td><td>0.94</td><td>0.586</td><td>0.881</td><td>1.000</td><td>722</td><td>tags=88%, list=63%, signal=235%</td></tr><tr><td class='lessen'>295</td><td>DANG_BOUND_BY_MYC</td><td></td><td>41</td><td>0.29</td><td>0.94</td><td>0.635</td><td>0.884</td><td>1.000</td><td>712</td><td>tags=78%, list=62%, signal=199%</td></tr><tr><td class='lessen'>296</td><td>YOSHIMURA_MAPK8_TARGETS_UP</td><td></td><td>94</td><td>0.27</td><td>0.94</td><td>0.674</td><td>0.887</td><td>1.000</td><td>515</td><td>tags=47%, list=45%, signal=78%</td></tr><tr><td class='lessen'>297</td><td>LOPEZ_MBD_TARGETS</td><td></td><td>42</td><td>0.29</td><td>0.93</td><td>0.633</td><td>0.892</td><td>1.000</td><td>430</td><td>tags=43%, list=38%, signal=66%</td></tr><tr><td class='lessen'>298</td><td>NABA_MATRISOME_ASSOCIATED</td><td></td><td>66</td><td>0.27</td><td>0.93</td><td>0.665</td><td>0.889</td><td>1.000</td><td>471</td><td>tags=42%, list=41%, signal=68%</td></tr><tr><td class='lessen'>299</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4</td><td></td><td>17</td><td>0.33</td><td>0.93</td><td>0.603</td><td>0.889</td><td>1.000</td><td>335</td><td>tags=35%, list=29%, signal=49%</td></tr><tr><td class='lessen'>300</td><td>YAGI_AML_WITH_INV_16_TRANSLOCATION</td><td></td><td>20</td><td>0.31</td><td>0.93</td><td>0.611</td><td>0.888</td><td>1.000</td><td>338</td><td>tags=40%, list=30%, signal=56%</td></tr><tr><td class='lessen'>301</td><td>LIAO_METASTASIS</td><td></td><td>23</td><td>0.31</td><td>0.93</td><td>0.611</td><td>0.892</td><td>1.000</td><td>521</td><td>tags=57%, list=46%, signal=102%</td></tr><tr><td class='lessen'>302</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP</td><td></td><td>15</td><td>0.33</td><td>0.93</td><td>0.582</td><td>0.889</td><td>1.000</td><td>570</td><td>tags=60%, list=50%, signal=118%</td></tr><tr><td class='lessen'>303</td><td>REACTOME_VESICLE_MEDIATED_TRANSPORT</td><td></td><td>41</td><td>0.28</td><td>0.92</td><td>0.645</td><td>0.898</td><td>1.000</td><td>386</td><td>tags=37%, list=34%, signal=53%</td></tr><tr><td class='lessen'>304</td><td>MILI_PSEUDOPODIA_CHEMOTAXIS_DN</td><td></td><td>22</td><td>0.31</td><td>0.92</td><td>0.637</td><td>0.908</td><td>1.000</td><td>741</td><td>tags=77%, list=65%, signal=215%</td></tr><tr><td class='lessen'>305</td><td>BILD_HRAS_ONCOGENIC_SIGNATURE</td><td></td><td>16</td><td>0.33</td><td>0.92</td><td>0.620</td><td>0.907</td><td>1.000</td><td>343</td><td>tags=38%, list=30%, signal=53%</td></tr><tr><td class='lessen'>306</td><td>DELACROIX_RARG_BOUND_MEF</td><td></td><td>23</td><td>0.30</td><td>0.91</td><td>0.636</td><td>0.908</td><td>1.000</td><td>658</td><td>tags=70%, list=57%, signal=160%</td></tr><tr><td class='lessen'>307</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP</td><td></td><td>22</td><td>0.30</td><td>0.91</td><td>0.643</td><td>0.906</td><td>1.000</td><td>365</td><td>tags=41%, list=32%, signal=59%</td></tr><tr><td class='lessen'>308</td><td>BROWNE_HCMV_INFECTION_14HR_DN</td><td></td><td>15</td><td>0.32</td><td>0.91</td><td>0.615</td><td>0.905</td><td>1.000</td><td>123</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>309</td><td>TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C</td><td></td><td>18</td><td>0.31</td><td>0.91</td><td>0.616</td><td>0.907</td><td>1.000</td><td>600</td><td>tags=61%, list=52%, signal=126%</td></tr><tr><td class='lessen'>310</td><td>KIM_WT1_TARGETS_UP</td><td></td><td>22</td><td>0.30</td><td>0.91</td><td>0.645</td><td>0.907</td><td>1.000</td><td>537</td><td>tags=50%, list=47%, signal=92%</td></tr><tr><td class='lessen'>311</td><td>REACTOME_NEURONAL_SYSTEM</td><td></td><td>18</td><td>0.31</td><td>0.91</td><td>0.635</td><td>0.912</td><td>1.000</td><td>541</td><td>tags=56%, list=47%, signal=104%</td></tr><tr><td class='lessen'>312</td><td>HELLER_HDAC_TARGETS_UP</td><td></td><td>18</td><td>0.31</td><td>0.90</td><td>0.632</td><td>0.915</td><td>1.000</td><td>395</td><td>tags=44%, list=34%, signal=67%</td></tr><tr><td class='lessen'>313</td><td>HOLLMANN_APOPTOSIS_VIA_CD40_DN</td><td></td><td>15</td><td>0.32</td><td>0.90</td><td>0.655</td><td>0.914</td><td>1.000</td><td>475</td><td>tags=53%, list=41%, signal=90%</td></tr><tr><td class='lessen'>314</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN</td><td></td><td>35</td><td>0.28</td><td>0.90</td><td>0.672</td><td>0.914</td><td>1.000</td><td>488</td><td>tags=49%, list=43%, signal=82%</td></tr><tr><td class='lessen'>315</td><td>ONKEN_UVEAL_MELANOMA_UP</td><td></td><td>34</td><td>0.28</td><td>0.90</td><td>0.679</td><td>0.912</td><td>1.000</td><td>332</td><td>tags=35%, list=29%, signal=48%</td></tr><tr><td class='lessen'>316</td><td>DELYS_THYROID_CANCER_DN</td><td></td><td>19</td><td>0.31</td><td>0.90</td><td>0.670</td><td>0.911</td><td>1.000</td><td>622</td><td>tags=68%, list=54%, signal=147%</td></tr><tr><td class='lessen'>317</td><td>REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION</td><td></td><td>17</td><td>0.31</td><td>0.90</td><td>0.648</td><td>0.913</td><td>1.000</td><td>569</td><td>tags=53%, list=50%, signal=104%</td></tr><tr><td class='lessen'>318</td><td>BROWNE_HCMV_INFECTION_48HR_DN</td><td></td><td>26</td><td>0.29</td><td>0.90</td><td>0.654</td><td>0.912</td><td>1.000</td><td>488</td><td>tags=50%, list=43%, signal=85%</td></tr><tr><td class='lessen'>319</td><td>DODD_NASOPHARYNGEAL_CARCINOMA_UP</td><td></td><td>128</td><td>0.25</td><td>0.90</td><td>0.788</td><td>0.911</td><td>1.000</td><td>675</td><td>tags=61%, list=59%, signal=132%</td></tr><tr><td class='lessen'>320</td><td>SHEN_SMARCA2_TARGETS_DN</td><td></td><td>27</td><td>0.29</td><td>0.90</td><td>0.676</td><td>0.908</td><td>1.000</td><td>502</td><td>tags=48%, list=44%, signal=84%</td></tr><tr><td class='lessen'>321</td><td>LEE_BMP2_TARGETS_UP</td><td></td><td>47</td><td>0.27</td><td>0.90</td><td>0.675</td><td>0.906</td><td>1.000</td><td>741</td><td>tags=81%, list=65%, signal=220%</td></tr><tr><td class='lessen'>322</td><td>IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR</td><td></td><td>16</td><td>0.32</td><td>0.90</td><td>0.652</td><td>0.904</td><td>1.000</td><td>455</td><td>tags=44%, list=40%, signal=72%</td></tr><tr><td class='lessen'>323</td><td>THUM_SYSTOLIC_HEART_FAILURE_UP</td><td></td><td>22</td><td>0.30</td><td>0.90</td><td>0.661</td><td>0.902</td><td>1.000</td><td>443</td><td>tags=41%, list=39%, signal=65%</td></tr><tr><td class='lessen'>324</td><td>POOLA_INVASIVE_BREAST_CANCER_UP</td><td></td><td>19</td><td>0.31</td><td>0.89</td><td>0.665</td><td>0.908</td><td>1.000</td><td>703</td><td>tags=68%, list=61%, signal=174%</td></tr><tr><td class='lessen'>325</td><td>KUMAR_TARGETS_OF_MLL_AF9_FUSION</td><td></td><td>27</td><td>0.29</td><td>0.89</td><td>0.665</td><td>0.905</td><td>1.000</td><td>540</td><td>tags=48%, list=47%, signal=89%</td></tr><tr><td class='lessen'>326</td><td>ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP</td><td></td><td>18</td><td>0.31</td><td>0.89</td><td>0.666</td><td>0.908</td><td>1.000</td><td>638</td><td>tags=72%, list=56%, signal=161%</td></tr><tr><td class='lessen'>327</td><td>KEGG_MAPK_SIGNALING_PATHWAY</td><td></td><td>18</td><td>0.31</td><td>0.89</td><td>0.674</td><td>0.908</td><td>1.000</td><td>583</td><td>tags=56%, list=51%, signal=111%</td></tr><tr><td class='lessen'>328</td><td>CHYLA_CBFA2T3_TARGETS_DN</td><td></td><td>17</td><td>0.31</td><td>0.88</td><td>0.682</td><td>0.914</td><td>1.000</td><td>452</td><td>tags=47%, list=39%, signal=77%</td></tr><tr><td class='lessen'>329</td><td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP</td><td></td><td>42</td><td>0.27</td><td>0.88</td><td>0.727</td><td>0.912</td><td>1.000</td><td>704</td><td>tags=69%, list=61%, signal=173%</td></tr><tr><td class='lessen'>330</td><td>NABA_ECM_REGULATORS</td><td></td><td>20</td><td>0.30</td><td>0.88</td><td>0.673</td><td>0.913</td><td>1.000</td><td>741</td><td>tags=80%, list=65%, signal=223%</td></tr><tr><td class='lessen'>331</td><td>NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON</td><td></td><td>23</td><td>0.29</td><td>0.88</td><td>0.682</td><td>0.917</td><td>1.000</td><td>604</td><td>tags=61%, list=53%, signal=126%</td></tr><tr><td class='lessen'>332</td><td>ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN</td><td></td><td>57</td><td>0.26</td><td>0.88</td><td>0.733</td><td>0.919</td><td>1.000</td><td>753</td><td>tags=77%, list=66%, signal=214%</td></tr><tr><td class='lessen'>333</td><td>GOZGIT_ESR1_TARGETS_DN</td><td></td><td>44</td><td>0.27</td><td>0.88</td><td>0.738</td><td>0.917</td><td>1.000</td><td>677</td><td>tags=68%, list=59%, signal=160%</td></tr><tr><td class='lessen'>334</td><td>NABA_MATRISOME</td><td></td><td>87</td><td>0.25</td><td>0.87</td><td>0.792</td><td>0.923</td><td>1.000</td><td>473</td><td>tags=41%, list=41%, signal=65%</td></tr><tr><td class='lessen'>335</td><td>REACTOME_RHO_GTPASE_EFFECTORS</td><td></td><td>16</td><td>0.31</td><td>0.87</td><td>0.696</td><td>0.921</td><td>1.000</td><td>442</td><td>tags=38%, list=39%, signal=60%</td></tr><tr><td class='lessen'>336</td><td>LIM_MAMMARY_STEM_CELL_DN</td><td></td><td>26</td><td>0.29</td><td>0.87</td><td>0.725</td><td>0.919</td><td>1.000</td><td>610</td><td>tags=54%, list=53%, signal=113%</td></tr><tr><td class='lessen'>337</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN</td><td></td><td>33</td><td>0.27</td><td>0.87</td><td>0.726</td><td>0.917</td><td>1.000</td><td>785</td><td>tags=82%, list=69%, signal=253%</td></tr><tr><td class='lessen'>338</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3</td><td></td><td>52</td><td>0.26</td><td>0.86</td><td>0.787</td><td>0.935</td><td>1.000</td><td>643</td><td>tags=62%, list=56%, signal=134%</td></tr><tr><td class='lessen'>339</td><td>HUTTMANN_B_CLL_POOR_SURVIVAL_UP</td><td></td><td>24</td><td>0.28</td><td>0.86</td><td>0.726</td><td>0.933</td><td>1.000</td><td>651</td><td>tags=67%, list=57%, signal=151%</td></tr><tr><td class='lessen'>340</td><td>SENESE_HDAC1_AND_HDAC2_TARGETS_UP</td><td></td><td>19</td><td>0.29</td><td>0.85</td><td>0.734</td><td>0.941</td><td>1.000</td><td>723</td><td>tags=79%, list=63%, signal=211%</td></tr><tr><td class='lessen'>341</td><td>KOYAMA_SEMA3B_TARGETS_UP</td><td></td><td>16</td><td>0.30</td><td>0.85</td><td>0.713</td><td>0.945</td><td>1.000</td><td>215</td><td>tags=25%, list=19%, signal=30%</td></tr><tr><td class='lessen'>342</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN</td><td></td><td>21</td><td>0.28</td><td>0.85</td><td>0.728</td><td>0.946</td><td>1.000</td><td>453</td><td>tags=43%, list=40%, signal=70%</td></tr><tr><td class='lessen'>343</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN</td><td></td><td>22</td><td>0.29</td><td>0.84</td><td>0.755</td><td>0.953</td><td>1.000</td><td>590</td><td>tags=59%, list=52%, signal=120%</td></tr><tr><td class='lessen'>344</td><td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP</td><td></td><td>18</td><td>0.29</td><td>0.84</td><td>0.737</td><td>0.953</td><td>1.000</td><td>169</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>345</td><td>REACTOME_ADAPTIVE_IMMUNE_SYSTEM</td><td></td><td>45</td><td>0.25</td><td>0.84</td><td>0.799</td><td>0.953</td><td>1.000</td><td>270</td><td>tags=24%, list=24%, signal=31%</td></tr><tr><td class='lessen'>346</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN</td><td></td><td>55</td><td>0.25</td><td>0.84</td><td>0.823</td><td>0.959</td><td>1.000</td><td>633</td><td>tags=55%, list=55%, signal=116%</td></tr><tr><td class='lessen'>347</td><td>JAEGER_METASTASIS_DN</td><td></td><td>25</td><td>0.28</td><td>0.84</td><td>0.767</td><td>0.956</td><td>1.000</td><td>439</td><td>tags=44%, list=38%, signal=70%</td></tr><tr><td class='lessen'>348</td><td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN</td><td></td><td>22</td><td>0.28</td><td>0.84</td><td>0.748</td><td>0.954</td><td>1.000</td><td>589</td><td>tags=59%, list=51%, signal=119%</td></tr><tr><td class='lessen'>349</td><td>PLASARI_TGFB1_TARGETS_10HR_UP</td><td></td><td>18</td><td>0.29</td><td>0.84</td><td>0.733</td><td>0.953</td><td>1.000</td><td>305</td><td>tags=28%, list=27%, signal=37%</td></tr><tr><td class='lessen'>350</td><td>REACTOME_FLT3_SIGNALING</td><td></td><td>21</td><td>0.27</td><td>0.83</td><td>0.761</td><td>0.963</td><td>1.000</td><td>576</td><td>tags=48%, list=50%, signal=94%</td></tr><tr><td class='lessen'>351</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_UP</td><td></td><td>15</td><td>0.29</td><td>0.83</td><td>0.729</td><td>0.962</td><td>1.000</td><td>223</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>352</td><td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</td><td></td><td>31</td><td>0.26</td><td>0.83</td><td>0.771</td><td>0.959</td><td>1.000</td><td>612</td><td>tags=52%, list=53%, signal=108%</td></tr><tr><td class='lessen'>353</td><td>NABA_ECM_GLYCOPROTEINS</td><td></td><td>19</td><td>0.28</td><td>0.82</td><td>0.760</td><td>0.960</td><td>1.000</td><td>678</td><td>tags=68%, list=59%, signal=165%</td></tr><tr><td class='lessen'>354</td><td>MARTENS_BOUND_BY_PML_RARA_FUSION</td><td></td><td>31</td><td>0.26</td><td>0.82</td><td>0.795</td><td>0.958</td><td>1.000</td><td>696</td><td>tags=68%, list=61%, signal=168%</td></tr><tr><td class='lessen'>355</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN</td><td></td><td>27</td><td>0.27</td><td>0.82</td><td>0.780</td><td>0.956</td><td>1.000</td><td>589</td><td>tags=56%, list=51%, signal=112%</td></tr><tr><td class='lessen'>356</td><td>MIKKELSEN_MCV6_LCP_WITH_H3K4ME3</td><td></td><td>16</td><td>0.29</td><td>0.82</td><td>0.745</td><td>0.954</td><td>1.000</td><td>343</td><td>tags=38%, list=30%, signal=53%</td></tr><tr><td class='lessen'>357</td><td>DELYS_THYROID_CANCER_UP</td><td></td><td>25</td><td>0.27</td><td>0.82</td><td>0.794</td><td>0.952</td><td>1.000</td><td>691</td><td>tags=72%, list=60%, signal=178%</td></tr><tr><td class='lessen'>358</td><td>WIERENGA_STAT5A_TARGETS_UP</td><td></td><td>19</td><td>0.28</td><td>0.82</td><td>0.749</td><td>0.954</td><td>1.000</td><td>690</td><td>tags=68%, list=60%, signal=169%</td></tr><tr><td class='lessen'>359</td><td>ACEVEDO_LIVER_CANCER_DN</td><td></td><td>38</td><td>0.25</td><td>0.82</td><td>0.821</td><td>0.954</td><td>1.000</td><td>466</td><td>tags=39%, list=41%, signal=64%</td></tr><tr><td class='lessen'>360</td><td>MCCABE_BOUND_BY_HOXC6</td><td></td><td>23</td><td>0.27</td><td>0.82</td><td>0.772</td><td>0.955</td><td>1.000</td><td>634</td><td>tags=61%, list=55%, signal=134%</td></tr><tr><td class='lessen'>361</td><td>ENK_UV_RESPONSE_EPIDERMIS_DN</td><td></td><td>22</td><td>0.27</td><td>0.81</td><td>0.791</td><td>0.956</td><td>1.000</td><td>371</td><td>tags=36%, list=32%, signal=53%</td></tr><tr><td class='lessen'>362</td><td>HAMAI_APOPTOSIS_VIA_TRAIL_DN</td><td></td><td>15</td><td>0.29</td><td>0.81</td><td>0.751</td><td>0.963</td><td>1.000</td><td>692</td><td>tags=67%, list=60%, signal=166%</td></tr><tr><td class='lessen'>363</td><td>ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY</td><td></td><td>106</td><td>0.23</td><td>0.81</td><td>0.935</td><td>0.964</td><td>1.000</td><td>455</td><td>tags=38%, list=40%, signal=57%</td></tr><tr><td class='lessen'>364</td><td>PASINI_SUZ12_TARGETS_DN</td><td></td><td>22</td><td>0.27</td><td>0.80</td><td>0.804</td><td>0.962</td><td>1.000</td><td>576</td><td>tags=59%, list=50%, signal=117%</td></tr><tr><td class='lessen'>365</td><td>ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN</td><td></td><td>24</td><td>0.26</td><td>0.80</td><td>0.808</td><td>0.965</td><td>1.000</td><td>574</td><td>tags=50%, list=50%, signal=98%</td></tr><tr><td class='lessen'>366</td><td>BENPORATH_MYC_MAX_TARGETS</td><td></td><td>30</td><td>0.25</td><td>0.80</td><td>0.816</td><td>0.964</td><td>1.000</td><td>753</td><td>tags=77%, list=66%, signal=218%</td></tr><tr><td class='lessen'>367</td><td>SMID_BREAST_CANCER_NORMAL_LIKE_UP</td><td></td><td>40</td><td>0.25</td><td>0.80</td><td>0.863</td><td>0.964</td><td>1.000</td><td>538</td><td>tags=43%, list=47%, signal=77%</td></tr><tr><td class='lessen'>368</td><td>ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN</td><td></td><td>18</td><td>0.27</td><td>0.80</td><td>0.775</td><td>0.962</td><td>1.000</td><td>716</td><td>tags=67%, list=63%, signal=175%</td></tr><tr><td class='lessen'>369</td><td>PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN</td><td></td><td>26</td><td>0.26</td><td>0.80</td><td>0.825</td><td>0.959</td><td>1.000</td><td>587</td><td>tags=54%, list=51%, signal=108%</td></tr><tr><td class='lessen'>370</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN</td><td></td><td>31</td><td>0.25</td><td>0.79</td><td>0.831</td><td>0.962</td><td>1.000</td><td>785</td><td>tags=77%, list=69%, signal=240%</td></tr><tr><td class='lessen'>371</td><td>MULLIGHAN_MLL_SIGNATURE_2_DN</td><td></td><td>16</td><td>0.28</td><td>0.79</td><td>0.779</td><td>0.963</td><td>1.000</td><td>292</td><td>tags=25%, list=26%, signal=33%</td></tr><tr><td class='lessen'>372</td><td>BENPORATH_CYCLING_GENES</td><td></td><td>23</td><td>0.26</td><td>0.79</td><td>0.821</td><td>0.965</td><td>1.000</td><td>636</td><td>tags=57%, list=56%, signal=125%</td></tr><tr><td class='lessen'>373</td><td>REACTOME_MEMBRANE_TRAFFICKING</td><td></td><td>38</td><td>0.25</td><td>0.79</td><td>0.851</td><td>0.962</td><td>1.000</td><td>386</td><td>tags=34%, list=34%, signal=50%</td></tr><tr><td class='lessen'>374</td><td>MITSIADES_RESPONSE_TO_APLIDIN_UP</td><td></td><td>17</td><td>0.27</td><td>0.78</td><td>0.804</td><td>0.968</td><td>1.000</td><td>704</td><td>tags=71%, list=61%, signal=181%</td></tr><tr><td class='lessen'>375</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1</td><td></td><td>16</td><td>0.28</td><td>0.78</td><td>0.796</td><td>0.966</td><td>1.000</td><td>704</td><td>tags=69%, list=61%, signal=176%</td></tr><tr><td class='lessen'>376</td><td>MARTENS_TRETINOIN_RESPONSE_UP</td><td></td><td>81</td><td>0.22</td><td>0.77</td><td>0.942</td><td>0.978</td><td>1.000</td><td>656</td><td>tags=53%, list=57%, signal=116%</td></tr><tr><td class='lessen'>377</td><td>SABATES_COLORECTAL_ADENOMA_DN</td><td></td><td>23</td><td>0.26</td><td>0.77</td><td>0.851</td><td>0.977</td><td>1.000</td><td>561</td><td>tags=43%, list=49%, signal=84%</td></tr><tr><td class='lessen'>378</td><td>PHONG_TNF_RESPONSE_NOT_VIA_P38</td><td></td><td>16</td><td>0.27</td><td>0.77</td><td>0.820</td><td>0.976</td><td>1.000</td><td>703</td><td>tags=75%, list=61%, signal=192%</td></tr><tr><td class='lessen'>379</td><td>LU_EZH2_TARGETS_DN</td><td></td><td>25</td><td>0.25</td><td>0.77</td><td>0.851</td><td>0.974</td><td>1.000</td><td>533</td><td>tags=44%, list=47%, signal=81%</td></tr><tr><td class='lessen'>380</td><td>REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS</td><td></td><td>16</td><td>0.27</td><td>0.76</td><td>0.819</td><td>0.976</td><td>1.000</td><td>574</td><td>tags=50%, list=50%, signal=99%</td></tr><tr><td class='lessen'>381</td><td>YAGI_AML_WITH_T_8_21_TRANSLOCATION</td><td></td><td>19</td><td>0.26</td><td>0.76</td><td>0.829</td><td>0.975</td><td>1.000</td><td>711</td><td>tags=74%, list=62%, signal=191%</td></tr><tr><td class='lessen'>382</td><td>KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION</td><td></td><td>25</td><td>0.25</td><td>0.75</td><td>0.862</td><td>0.983</td><td>1.000</td><td>573</td><td>tags=40%, list=50%, signal=78%</td></tr><tr><td class='lessen'>383</td><td>STEIN_ESRRA_TARGETS_UP</td><td></td><td>18</td><td>0.26</td><td>0.75</td><td>0.871</td><td>0.983</td><td>1.000</td><td>428</td><td>tags=39%, list=37%, signal=61%</td></tr><tr><td class='lessen'>384</td><td>FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL</td><td></td><td>25</td><td>0.25</td><td>0.75</td><td>0.861</td><td>0.983</td><td>1.000</td><td>796</td><td>tags=72%, list=70%, signal=231%</td></tr><tr><td class='lessen'>385</td><td>MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>19</td><td>0.26</td><td>0.75</td><td>0.868</td><td>0.983</td><td>1.000</td><td>529</td><td>tags=37%, list=46%, signal=67%</td></tr><tr><td class='lessen'>386</td><td>STEIN_ESRRA_TARGETS</td><td></td><td>27</td><td>0.24</td><td>0.75</td><td>0.871</td><td>0.981</td><td>1.000</td><td>704</td><td>tags=67%, list=61%, signal=169%</td></tr><tr><td class='lessen'>387</td><td>REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC</td><td></td><td>15</td><td>0.27</td><td>0.75</td><td>0.833</td><td>0.979</td><td>1.000</td><td>783</td><td>tags=73%, list=68%, signal=229%</td></tr><tr><td class='lessen'>388</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td><td></td><td>31</td><td>0.24</td><td>0.74</td><td>0.882</td><td>0.980</td><td>1.000</td><td>799</td><td>tags=81%, list=70%, signal=260%</td></tr><tr><td class='lessen'>389</td><td>GENTILE_UV_HIGH_DOSE_DN</td><td></td><td>15</td><td>0.26</td><td>0.74</td><td>0.869</td><td>0.980</td><td>1.000</td><td>748</td><td>tags=80%, list=65%, signal=228%</td></tr><tr><td class='lessen'>390</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN</td><td></td><td>19</td><td>0.25</td><td>0.74</td><td>0.856</td><td>0.978</td><td>1.000</td><td>559</td><td>tags=53%, list=49%, signal=101%</td></tr><tr><td class='lessen'>391</td><td>LIM_MAMMARY_STEM_CELL_UP</td><td></td><td>30</td><td>0.23</td><td>0.74</td><td>0.896</td><td>0.976</td><td>1.000</td><td>669</td><td>tags=63%, list=58%, signal=148%</td></tr><tr><td class='lessen'>392</td><td>REACTOME_INNATE_IMMUNE_SYSTEM</td><td></td><td>68</td><td>0.22</td><td>0.74</td><td>0.947</td><td>0.977</td><td>1.000</td><td>567</td><td>tags=47%, list=50%, signal=88%</td></tr><tr><td class='lessen'>393</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS</td><td></td><td>37</td><td>0.23</td><td>0.74</td><td>0.908</td><td>0.976</td><td>1.000</td><td>440</td><td>tags=38%, list=38%, signal=59%</td></tr><tr><td class='lessen'>394</td><td>NUYTTEN_NIPP1_TARGETS_DN</td><td></td><td>39</td><td>0.23</td><td>0.73</td><td>0.917</td><td>0.975</td><td>1.000</td><td>793</td><td>tags=67%, list=69%, signal=209%</td></tr><tr><td class='lessen'>395</td><td>JOHNSTONE_PARVB_TARGETS_3_UP</td><td></td><td>22</td><td>0.24</td><td>0.73</td><td>0.872</td><td>0.975</td><td>1.000</td><td>799</td><td>tags=77%, list=70%, signal=251%</td></tr><tr><td class='lessen'>396</td><td>RATTENBACHER_BOUND_BY_CELF1</td><td></td><td>21</td><td>0.25</td><td>0.73</td><td>0.878</td><td>0.973</td><td>1.000</td><td>681</td><td>tags=67%, list=59%, signal=161%</td></tr><tr><td class='lessen'>397</td><td>PEREZ_TP63_TARGETS</td><td></td><td>21</td><td>0.25</td><td>0.72</td><td>0.887</td><td>0.977</td><td>1.000</td><td>556</td><td>tags=48%, list=49%, signal=91%</td></tr><tr><td class='lessen'>398</td><td>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP</td><td></td><td>21</td><td>0.24</td><td>0.72</td><td>0.872</td><td>0.977</td><td>1.000</td><td>562</td><td>tags=52%, list=49%, signal=101%</td></tr><tr><td class='lessen'>399</td><td>WEST_ADRENOCORTICAL_TUMOR_DN</td><td></td><td>31</td><td>0.23</td><td>0.72</td><td>0.919</td><td>0.975</td><td>1.000</td><td>728</td><td>tags=65%, list=64%, signal=172%</td></tr><tr><td class='lessen'>400</td><td>REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION</td><td></td><td>16</td><td>0.25</td><td>0.72</td><td>0.868</td><td>0.975</td><td>1.000</td><td>657</td><td>tags=63%, list=57%, signal=145%</td></tr><tr><td class='lessen'>401</td><td>OHGUCHI_LIVER_HNF4A_TARGETS_DN</td><td></td><td>20</td><td>0.24</td><td>0.72</td><td>0.892</td><td>0.973</td><td>1.000</td><td>762</td><td>tags=65%, list=67%, signal=191%</td></tr><tr><td class='lessen'>402</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP</td><td></td><td>29</td><td>0.23</td><td>0.72</td><td>0.903</td><td>0.972</td><td>1.000</td><td>205</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>403</td><td>VERHAAK_GLIOBLASTOMA_MESENCHYMAL</td><td></td><td>17</td><td>0.25</td><td>0.71</td><td>0.896</td><td>0.974</td><td>1.000</td><td>765</td><td>tags=76%, list=67%, signal=227%</td></tr><tr><td class='lessen'>404</td><td>LEE_LIVER_CANCER_SURVIVAL_UP</td><td></td><td>16</td><td>0.25</td><td>0.71</td><td>0.886</td><td>0.975</td><td>1.000</td><td>454</td><td>tags=38%, list=40%, signal=61%</td></tr><tr><td class='lessen'>405</td><td>COLINA_TARGETS_OF_4EBP1_AND_4EBP2</td><td></td><td>20</td><td>0.24</td><td>0.71</td><td>0.884</td><td>0.973</td><td>1.000</td><td>669</td><td>tags=60%, list=58%, signal=142%</td></tr><tr><td class='lessen'>406</td><td>MIKKELSEN_IPS_LCP_WITH_H3K4ME3</td><td></td><td>29</td><td>0.22</td><td>0.70</td><td>0.929</td><td>0.977</td><td>1.000</td><td>580</td><td>tags=48%, list=51%, signal=95%</td></tr><tr><td class='lessen'>407</td><td>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN</td><td></td><td>21</td><td>0.23</td><td>0.70</td><td>0.915</td><td>0.976</td><td>1.000</td><td>730</td><td>tags=71%, list=64%, signal=193%</td></tr><tr><td class='lessen'>408</td><td>REACTOME_DISEASES_OF_METABOLISM</td><td></td><td>15</td><td>0.25</td><td>0.69</td><td>0.894</td><td>0.979</td><td>1.000</td><td>721</td><td>tags=60%, list=63%, signal=160%</td></tr><tr><td class='lessen'>409</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S3</td><td></td><td>18</td><td>0.24</td><td>0.69</td><td>0.920</td><td>0.977</td><td>1.000</td><td>708</td><td>tags=61%, list=62%, signal=158%</td></tr><tr><td class='lessen'>410</td><td>NABA_CORE_MATRISOME</td><td></td><td>21</td><td>0.23</td><td>0.69</td><td>0.905</td><td>0.977</td><td>1.000</td><td>678</td><td>tags=62%, list=59%, signal=149%</td></tr><tr><td class='lessen'>411</td><td>RUTELLA_RESPONSE_TO_HGF_UP</td><td></td><td>21</td><td>0.22</td><td>0.68</td><td>0.916</td><td>0.982</td><td>1.000</td><td>590</td><td>tags=52%, list=52%, signal=106%</td></tr><tr><td class='lessen'>412</td><td>REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION</td><td></td><td>17</td><td>0.24</td><td>0.67</td><td>0.922</td><td>0.983</td><td>1.000</td><td>597</td><td>tags=53%, list=52%, signal=109%</td></tr><tr><td class='lessen'>413</td><td>LIU_PROSTATE_CANCER_DN</td><td></td><td>33</td><td>0.21</td><td>0.67</td><td>0.948</td><td>0.982</td><td>1.000</td><td>110</td><td>tags=15%, list=10%, signal=16%</td></tr><tr><td class='lessen'>414</td><td>HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP</td><td></td><td>16</td><td>0.23</td><td>0.66</td><td>0.920</td><td>0.985</td><td>1.000</td><td>619</td><td>tags=56%, list=54%, signal=121%</td></tr><tr><td class='lessen'>415</td><td>CAIRO_LIVER_DEVELOPMENT_DN</td><td></td><td>18</td><td>0.23</td><td>0.66</td><td>0.918</td><td>0.985</td><td>1.000</td><td>477</td><td>tags=39%, list=42%, signal=66%</td></tr><tr><td class='lessen'>416</td><td>QI_PLASMACYTOMA_UP</td><td></td><td>21</td><td>0.21</td><td>0.63</td><td>0.942</td><td>0.997</td><td>1.000</td><td>799</td><td>tags=71%, list=70%, signal=232%</td></tr><tr><td class='lessen'>417</td><td>AFFAR_YY1_TARGETS_UP</td><td></td><td>19</td><td>0.22</td><td>0.63</td><td>0.952</td><td>0.999</td><td>1.000</td><td>829</td><td>tags=84%, list=72%, signal=300%</td></tr><tr><td class='lessen'>418</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN</td><td></td><td>25</td><td>0.20</td><td>0.63</td><td>0.956</td><td>0.997</td><td>1.000</td><td>415</td><td>tags=32%, list=36%, signal=49%</td></tr><tr><td class='lessen'>419</td><td>MIKKELSEN_ES_LCP_WITH_H3K4ME3</td><td></td><td>22</td><td>0.21</td><td>0.62</td><td>0.952</td><td>0.995</td><td>1.000</td><td>96</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>420</td><td>SERVITJA_LIVER_HNF1A_TARGETS_DN</td><td></td><td>18</td><td>0.21</td><td>0.61</td><td>0.962</td><td>1.000</td><td>1.000</td><td>755</td><td>tags=61%, list=66%, signal=177%</td></tr><tr><td class='lessen'>421</td><td>SANSOM_APC_TARGETS_DN</td><td></td><td>31</td><td>0.19</td><td>0.61</td><td>0.976</td><td>0.998</td><td>1.000</td><td>423</td><td>tags=26%, list=37%, signal=40%</td></tr><tr><td class='lessen'>422</td><td>FARMER_BREAST_CANCER_BASAL_VS_LULMINAL</td><td></td><td>17</td><td>0.21</td><td>0.60</td><td>0.973</td><td>0.999</td><td>1.000</td><td>796</td><td>tags=71%, list=70%, signal=228%</td></tr><tr><td class='lessen'>423</td><td>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN</td><td></td><td>15</td><td>0.21</td><td>0.60</td><td>0.968</td><td>0.997</td><td>1.000</td><td>769</td><td>tags=67%, list=67%, signal=200%</td></tr><tr><td class='lessen'>424</td><td>MCLACHLAN_DENTAL_CARIES_UP</td><td></td><td>24</td><td>0.20</td><td>0.59</td><td>0.956</td><td>0.995</td><td>1.000</td><td>765</td><td>tags=67%, list=67%, signal=197%</td></tr><tr><td class='lessen'>425</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A</td><td></td><td>43</td><td>0.18</td><td>0.59</td><td>0.986</td><td>0.995</td><td>1.000</td><td>578</td><td>tags=44%, list=50%, signal=86%</td></tr><tr><td class='lessen'>426</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4</td><td></td><td>21</td><td>0.20</td><td>0.58</td><td>0.978</td><td>0.995</td><td>1.000</td><td>776</td><td>tags=57%, list=68%, signal=174%</td></tr><tr><td class='lessen'>427</td><td>RODWELL_AGING_KIDNEY_UP</td><td></td><td>36</td><td>0.18</td><td>0.57</td><td>0.988</td><td>0.995</td><td>1.000</td><td>794</td><td>tags=69%, list=69%, signal=219%</td></tr><tr><td class='lessen'>428</td><td>SMID_BREAST_CANCER_ERBB2_UP</td><td></td><td>15</td><td>0.20</td><td>0.56</td><td>0.968</td><td>0.996</td><td>1.000</td><td>493</td><td>tags=33%, list=43%, signal=58%</td></tr><tr><td class='lessen'>429</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP</td><td></td><td>29</td><td>0.18</td><td>0.56</td><td>0.985</td><td>0.995</td><td>1.000</td><td>726</td><td>tags=59%, list=63%, signal=156%</td></tr><tr><td class='lessen'>430</td><td>RUTELLA_RESPONSE_TO_HGF_DN</td><td></td><td>15</td><td>0.19</td><td>0.55</td><td>0.974</td><td>0.994</td><td>1.000</td><td>769</td><td>tags=67%, list=67%, signal=200%</td></tr><tr><td class='lessen'>431</td><td>HSIAO_LIVER_SPECIFIC_GENES</td><td></td><td>21</td><td>0.18</td><td>0.54</td><td>0.989</td><td>0.994</td><td>1.000</td><td>532</td><td>tags=38%, list=46%, signal=70%</td></tr><tr><td class='lessen'>432</td><td>REACTOME_TRANSPORT_OF_SMALL_MOLECULES</td><td></td><td>55</td><td>0.16</td><td>0.53</td><td>0.998</td><td>0.994</td><td>1.000</td><td>237</td><td>tags=16%, list=21%, signal=20%</td></tr><tr><td class='lessen'>433</td><td>BASAKI_YBX1_TARGETS_DN</td><td></td><td>19</td><td>0.17</td><td>0.49</td><td>0.995</td><td>0.997</td><td>1.000</td><td>130</td><td>tags=11%, list=11%, signal=12%</td></tr><tr><td class='lessen'>434</td><td>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP</td><td></td><td>15</td><td>0.17</td><td>0.48</td><td>0.996</td><td>0.995</td><td>1.000</td><td>769</td><td>tags=60%, list=67%, signal=180%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>na<b>&nbsp<a href='gsea_report_for_na_pos_1590890274474.xls'>[plain text format]</a></caption></table></div><br></body></html>